Dilated cardiomyopathy

I9_DILATED_CARDIOMYOPATHY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.0 Cause of death: ICD-10 — I42.0 2 out of 7 registries used, show all original rules.	4870
4. Check minimum number of events None	4870
5. Include endpoints None	4870
6. Filter based on genotype QC (FinnGen only)	4757

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF13

NAME	I9_DILATED_CARDIOMYOPATHY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I420
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I420
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dilated cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4757	1190	3567
Unadjusted period prevalence (%)	1.33	0.42	1.63
Median age at first event (years)	62.33	61.55	62.58

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4869: Matched controls
48690

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

11.5

307.7

1052

1136

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.4

307.7

1030

2821

I50.9

ICD-10 Finland

Heart failure, unspecified

15.5

307.7

3063

4794

C03CA01

ATC

furosemide; systemic

11.2

307.7

3791

11621

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

17.9

307.7

512

318

XF404

NOMESCO Finland

Ambulatory ECG

5.0

307.7

1093

2644

AN1

Coronary angiography

5.6

307.7

1660

4128

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

7.2

307.7

2588

6649

250, ,

Kela drug reimbursment

25.9

307.7

557

242

K77

ICPC

Heart failure

10.2

307.7

409

435

C03DA01

ATC

spironolactone; oral

19.6

307.7

2952

3552

I50.0

ICD-10 Finland

Congestive heart failure

11.4

307.7

1712

2212

I42.8

ICD-10 Finland

Other cardiomyopathies

52.8

307.7

222

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

34.8

307.7

310

I50

ICD-10 Finland

Heart failure

8.2

307.7

538

728

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

94.5

307.7

268

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

113.3

307.7

1324

160

I50.1

ICD-10 Finland

Left ventricular failure

25.0

307.7

1996

1315

207

Kela drug reimbursment

Chronic arrhythmias

5.0

307.7

1937

5729

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.1

307.7

2554

8727

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

43.1

307.7

269

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

73.4

307.7

825

135

C09AA05

ATC

ramipril; oral

5.9

307.7

2912

9770

201

Kela drug reimbursment

Chronic cardiac insufficiency

56.1

307.7

2849

1195

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

13.5

307.7

1408

1427

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

66.7

307.7

694

121

C01BD01

ATC

amiodarone; systemic

13.9

307.7

841

720

C09DX04

ATC

valsartan and sacubitril; oral

73.0

307.7

786

128

I48

ICD-10 Finland

Atrial fibrillation and flutter

4.7

307.7

2477

8860

A10BK01

ATC

dapagliflozin; oral

4.8

307.7

860

2083

GD1LA

NOMESCO Finland

13.1

307.7

388

320

1CX08, ,

NOMESCO Finland

38.9

307.7

223

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

17.2

307.7

433

274

C01AA05

ATC

digoxin; systemic

8.5

307.7

1459

2338

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

83.3

307.7

312

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

7.3

307.7

3077

9312

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

12.9

307.7

1733

1998

C07AB07

ATC

bisoprolol; oral

8.9

307.7

4195

20046

B01AA03

ATC

warfarin; systemic

5.8

307.7

2509

7566

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

24.6

307.7

296

128

TFP20

NOMESCO Finland

Cardiodefibrillation

4.7

307.7

970

2427

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

25.3

307.7

458

199

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

106.0

307.7

354

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

49.0

307.7

238

I47.2

ICD-10 Finland

Ventricular tachycardia

18.8

307.7

705

435

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4503599627370496.0

307.7

4868

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

20.5

307.7

270

139

Z94.1

ICD-10 Finland

Heart transplant status

73.3

302.1

163

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

10.9

282.2

310

301

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.2

277.2

1531

6162

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

263.4

3095

18481

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

256.0

1512

6282

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

13.2

245.6

237

188

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

235.4

1346

5458

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

8.1

234.6

325

426

AP4

Myocardial biopsy

103.4

234.4

121

TFJ02

NOMESCO Finland

Muscle biopsy of heart

49.8

226.6

131

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.4

217.2

602

1518

R06.0

ICD-10 Finland

Dyspnoea

2.6

217.0

1832

9042

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.8

210.0

712

2077

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

91.1

204.2

107

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

202.7

1276

5398

AS7

Arrhythmia pacemaker insertion VVI (R) S

39.4

201.4

123

Angiography of the heart and coronary arteries

3.8

201.3

703

2090

I42

ICD-10 Finland

Cardiomyopathy

678.8

199.7

196

M04AA01

ATC

allopurinol; systemic

2.8

199.3

1248

5259

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

502.7

195.9

194

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.6

186.0

468

1090

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

23.4

182.6

132

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

33.0

176.2

113

K78

ICPC

Atrial fibrillation/flutter

3.3

174.3

762

2605

WX892

NOMESCO Finland

Monitored bed care

3.4

173.3

700

2278

WX740

NOMESCO Finland

Nitrogen oxide therapy

57.0

168.7

C07AG02

ATC

carvedilol; oral

3.7

167.1

586

1738

XF640, ,

NOMESCO Finland

5.4

166.8

346

683

AP1

Catheterization of the left side of the heart

7.2

165.2

253

370

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

6.7

161.9

265

416

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.3

161.8

1799

9796

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

30.1

160.6

106

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.0

159.3

220

286

I48.2

ICD-10 Finland

Chronic atrial fibrillation

4.1

158.1

472

1249

A10BK03

ATC

empagliflozin; oral

2.9

152.1

812

3100

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

6.9

151.4

240

364

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

73.0

146.1

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

16.0

145.7

125

Z2221

NOMESCO Finland

Medical doctor

2.3

144.1

1567

8374

K84

ICPC

Heart disease other

4.8

142.5

340

755

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

29.9

142.2

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

9.8

139.7

163

171

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

39.3

139.1

C07AA07

ATC

sotalol; systemic

4.1

137.9

402

1043

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

137.5

603

2050

B01AF02

ATC

apixaban; oral

2.6

136.3

984

4367

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

27.6

135.4

ZXE00

NOMESCO Finland

One hour or less

2.1

134.8

2113

12970

ZX120

NOMESCO Finland

Intravenous

2.9

132.5

699

2639

XF409

NOMESCO Finland

Other special ECG

13.7

132.4

124

A12BA01

ATC

potassium chloride; oral

4.0

131.2

396

1053

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

156.6

130.0

137

ZXD05

NOMESCO Finland

Urgent procedure

2.1

128.5

1751

10146

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.6

128.1

249

462

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.4

125.6

328

782

TFP34

NOMESCO Finland

Electrophysiological investigation

4.6

125.0

313

722

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.1

124.9

275

570

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

44.2

124.5

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

14.4

122.1

111

127

Kela drug reimbursment

Transplant complication

6.7

117.8

189

290

M10.9

ICD-10 Finland

Gout, unspecified

2.8

116.2

650

2523

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.7

116.1

387

1101

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.0

110.9

546

1975

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

108.1

830

3756

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

227.1

108.1

111

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

55.2

105.7

Z3231

NOMESCO Finland

Registered nurse

2.0

97.2

1560

9394

L04AD02

ATC

tacrolimus; systemic

8.1

97.2

131

165

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

35.7

95.6

WX872

NOMESCO Finland

Intensive care

3.0

94.5

451

1598

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.7

94.4

566

2266

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

92.6

1984

13090

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

22.2

92.4

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.2

92.3

382

1245

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.0

90.3

268

701

L04AA06

ATC

mycophenolic acid; systemic

5.4

90.2

181

345

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

88.3

1570

9722

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

86.6

1283

7466

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

45.9

84.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

84.5

981

5223

R4110

NOMESCO Finland

Physiotherapy

1.9

84.3

1500

9263

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

115.9

84.2

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

22.9

83.8

Electrophysiological Special Examination

9.5

83.5

106

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

25.5

83.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

82.8

806

4003

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

82.0

365

1240

TK800

NOMESCO Finland

Hemodialysis

4.3

81.9

219

530

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

27.8

81.1

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

25.1

81.1

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

80.5

1504

9408

AP2

Catheterization of the right side of the heart

12.8

80.3

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

40.4

78.9

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

23.1

78.6

H02AB06

ATC

prednisolone; systemic

1.8

78.2

2410

17445

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

46.4

78.1

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.5

78.1

278

823

R02

ICPC

Shortness of breath/dyspnoea

2.2

76.8

743

3672

B01AB05

ATC

enoxaparin; parenteral

1.8

75.8

1661

10868

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

11.1

75.5

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.4

74.8

572

2557

3AC01, ,

NOMESCO Finland

7.2

74.0

111

158

TK810

NOMESCO Finland

Hemofiltration

8.2

73.4

122

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

73.3

495

2090

E05.89

ICD-10 Finland

Other thyrotoxicosis

18.1

73.3

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

35.7

73.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

73.0

479

1995

XF402

NOMESCO Finland

ECG with work load test

2.2

72.4

700

3453

ZX108

NOMESCO Finland

Inhalation

8.1

71.6

120

C07AB02

ATC

metoprolol; systemic

1.9

70.7

1183

7097

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.4

70.5

179

416

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

5.3

69.8

142

274

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.7

69.4

405

1591

AP3

Catheterization of the right and left side of the heart

15.1

69.1

C09AA04

ATC

perindopril; oral

2.7

68.0

381

1465

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

66.0

1806

12471

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.8

65.9

343

1269

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

65.1

270

878

TFP35

NOMESCO Finland

Electroanatomical mapping

4.8

63.5

145

309

C09AA02

ATC

enalapril; systemic

1.8

63.5

1169

7191

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

12.5

63.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

63.2

645

3241

Initial pacemaker installation

8.6

63.1

Catheterization and pressure measurement of the right side of the heart

10.3

61.7

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

61.4

525

2455

I47.1

ICD-10 Finland

Supraventricular tachycardia

3.1

61.2

274

932

A46

ICD-10 Finland

Erysipelas

1.9

60.6

896

5132

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

59.9

708

3753

Z3226

NOMESCO Finland

Physiotherapist

1.9

59.9

944

5520

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

3.7

59.7

197

554

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

59.7

1053

6378

I49.5

ICD-10 Finland

Sick sinus syndrome

2.9

58.9

288

1029

AQ1

Conventional electrophysiological examination

5.3

57.9

118

228

3A064, ,

NOMESCO Finland

9.6

57.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

57.7

688

3656

Initial installation of the atrial pacemaker

15.3

57.1

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.2

54.9

225

726

7AX01, ,

NOMESCO Finland

99.6

53.9

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

7.7

53.5

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

96.2

51.9

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.7

51.8

121

263

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

51.7

1533

10648

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.9

51.6

253

905

A10BA02

ATC

metformin; oral

1.6

50.8

1584

11132

M10.0

ICD-10 Finland

Idiopathic gout

2.7

49.8

281

1082

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

49.5

3192

36684

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

49.1

406

1865

FL1AC

NOMESCO Finland

Left cardioangiography

3.8

48.5

150

403

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

48.4

1407

9694

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.6

48.4

306

1246

742, ,

NOMESCO Finland

11.0

47.7

XFP02, ,

NOMESCO Finland

19.6

47.6

WX722

NOMESCO Finland

PEEP

2.5

47.5

320

1342

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

46.6

880

5394

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.1

46.3

198

655

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

46.2

173

528

N18.8

ICD-10 Finland

Other chronic renal failure

3.1

46.1

204

688

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

4.2

45.8

125

307

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.3

45.8

121

290

R03BB04

ATC

tiotropium bromide; inhalant

1.9

45.7

622

3441

C10AA01

ATC

simvastatin; oral

1.5

45.7

2313

18044

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.5

45.2

312

1323

Z2446

NOMESCO Finland

Social worker

2.4

45.0

340

1501

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

5.9

44.2

135

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

43.5

379

1777

H03BB01

ATC

carbimazole; oral

3.0

43.4

193

653

M01AH05

ATC

etoricoxib; oral

0.6

43.0

1718

22231

M10

ICD-10 Finland

Gout

2.3

42.7

332

1484

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

42.4

188

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.2

42.1

112

270

N19

ICD-10 Finland

Unspecified kidney failure

2.6

41.7

255

1021

C09AA01

ATC

captopril; oral

3.5

41.4

145

424

I34.1

ICD-10 Finland

Mitral (valve) prolapse

3.0

41.2

190

656

A10BH05

ATC

linagliptin; oral

2.3

40.9

339

1556

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

40.7

1414

10084

R55

ICD-10 Finland

Syncope and collapse

1.9

40.3

601

3417

K99

ICPC

Cardiovascular disease other

2.9

40.2

197

704

G04BE03

ATC

sildenafil; oral

3.4

40.0

148

448

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

6.1

39.6

115

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

7.7

39.5

C01BB02

ATC

mexiletine; systemic

12.3

39.3

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

39.2

423

2154

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

10.1

38.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

38.2

276

1194

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

38.2

727

4445

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

38.0

142

433

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

37.8

353

1700

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

37.7

306

1392

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

37.6

457

2427

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

37.4

1129

7769

5AB14, ,

NOMESCO Finland

14.3

37.3

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

37.1

830

5299

Catheterization and pressure measurement of the left side of the heart

3.4

37.0

138

420

R03AC02

ATC

salbutamol; inhalant

1.5

36.2

2301

18480

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

36.0

308

1432

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

35.4

354

1750

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

59.0

35.2

T90

ICPC

Diabetes non-insulin dependent

1.5

35.1

1278

9152

E66.8

ICD-10 Finland

Other obesity

2.5

34.8

226

931

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

6.3

34.6

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

11.3

34.4

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

34.0

597

3557

I44.6

ICD-10 Finland

Other and unspecified fascicular block

13.4

33.9

Cardiac muscle biopsy

76.7

33.8

ASA

Insertion of a biventricular pacemaker VVI (R) S

76.7

33.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

33.8

224

932

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

33.5

555

3250

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

33.5

1296

9387

J01FF01

ATC

clindamycin; systemic

1.5

33.5

1241

8907

AK1

HTX (heart transplant)

+∞

33.4

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

3.8

33.1

100

265

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

6.1

32.8

AA1AD

NOMESCO Finland

CT of head and brain

1.5

32.4

1372

10111

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

32.4

621

3792

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

32.4

148

509

FXE00

NOMESCO Finland

Use of ECLA

62.1

32.0

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

72.7

31.9

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.6

31.7

169

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

114.1

31.7

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.2

31.6

128

410

WX882

NOMESCO Finland

High dependency care

2.7

31.5

176

674

S97

ICPC

Chronic ulcer skin

2.0

30.9

348

1796

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

30.8

306

1508

Catheter ablation of arrhythmia

6.0

30.7

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.6

30.5

AS5

Biventricular heart failure pacemaker insertion VVI (R)

51.8

30.3

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

9.8

30.3

WX902

NOMESCO Finland

External defibrillation of heart

6.4

30.3

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

30.3

289

1403

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

30.1

284

1372

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

30.0

152

553

R2110

NOMESCO Finland

Giving the first information

2.2

30.0

258

1202

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

29.8

244

1113

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

29.8

523

3111

T92

ICPC

Gout

2.7

29.5

157

586

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

29.4

307

1541

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

29.3

483

2820

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

57.0

29.1

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

29.0

410

2283

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

28.9

293

1454

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

9.5

28.8

C09CA03

ATC

valsartan; oral

1.8

28.6

499

2962

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

28.6

1043

7424

A10AE04

ATC

insulin glargine; parenteral

1.7

28.6

519

3116

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.1

28.6

123

409

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

28.6

278

1359

K83

ICPC

Heart valve disease NOS

3.8

28.5

232

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

28.5

370

2004

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.4

28.5

105

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

3.4

28.1

100

296

WX730

NOMESCO Finland

Conventional respirator

3.3

27.9

107

332

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

27.7

203

884

R4190

NOMESCO Finland

Nutritional therapy

2.5

27.6

179

737

N17.8

ICD-10 Finland

Other acute renal failure

3.4

27.6

290

C10AA05

ATC

atorvastatin; oral

1.4

27.6

2135

17457

WX930

NOMESCO Finland

Thepapeutic hypothermia

9.2

27.4

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

27.1

288

1454

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

27.1

225

1033

A11CC03

ATC

alfacalcidol; systemic

2.7

27.0

149

567

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

62.4

26.9

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

24.8

26.5

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.3

26.3

208

936

I51.7

ICD-10 Finland

Cardiomegaly

6.4

26.0

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

25.9

205

922

R18

ICD-10 Finland

Ascites

2.9

25.7

119

413

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

25.6

145

559

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.6

811

5585

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

25.5

1171

8698

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

24.8

293

1537

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

24.7

271

1384

AS4

Physiological pacemaker insertion DDD (R)

3.2

24.3

309

C01DA14

ATC

isosorbide mononitrate; oral

1.5

24.1

874

6186

J01MA12

ATC

levofloxacin; systemic

1.5

24.0

908

6484

R04.0

ICD-10 Finland

Epistaxis

1.8

23.5

398

2338

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

23.4

555

3568

H02AB07

ATC

prednisone; oral

1.6

23.4

591

3859

C01BA03

ATC

disopyramide; systemic

4.6

23.1

118

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.9

23.0

107

372

C03AA03

ATC

hydrochlorothiazide; oral

1.7

23.0

442

2689

C08DA01

ATC

verapamil; systemic

2.2

23.0

203

955

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

22.9

275

1450

B01AF01

ATC

rivaroxaban; oral

1.6

22.8

633

4224

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

22.7

276

1461

A10BH01

ATC

sitagliptin; oral

1.6

22.7

505

3195

RS221, ,

NOMESCO Finland

3.4

22.7

236

N05CF01

ATC

zopiclone; oral

1.4

22.5

1396

10902

WW200

NOMESCO Finland

Immunization

2.5

22.4

143

585

ZX197, ,

NOMESCO Finland

32.4

22.4

J81

ICD-10 Finland

Pulmonary oedema

5.0

22.3

AS2

Ventricular pacemaker insertion VVI (R)

4.2

22.3

138

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

22.3

236

1191

J01MA14

ATC

moxifloxacin; systemic

1.7

22.2

430

2621

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

22.2

192

896

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

5.1

22.1

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.0

22.0

322

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

22.0

347

1995

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.8

21.8

171

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

21.7

288

1570

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

21.5

354

2062

K29

ICPC

Cardiovascular sympt/complt other

2.0

21.5

238

1220

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

26.5

21.3

R04.2

ICD-10 Finland

Haemoptysis

2.1

21.3

213

1053

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

21.2

349

2032

3A149, ,

NOMESCO Finland

33.9

21.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

21.0

315

B01AE07

ATC

dabigatran etexilate; oral

2.0

21.0

217

1085

WX002

NOMESCO Finland

Sedation and analgesia

1.5

21.0

865

6265

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

21.0

136

561

C01BA01

ATC

quinidine; oral

4.3

20.8

124

A10BJ06

ATC

semaglutide; parenteral

2.0

20.6

235

1218

FXG00

NOMESCO Finland

Insertion and use of IABP

6.3

20.5

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

20.4

116

449

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

22.4

20.3

A02BC02

ATC

pantoprazole; systemic

1.3

20.1

3017

26757

J01CA04

ATC

amoxicillin; systemic

1.4

20.1

3478

31512

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

20.0

819

5920

J01DB01

ATC

cefalexin; oral

1.4

19.9

3689

33756

120, ,

NOMESCO Finland

35.9

19.8

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

19.8

213

1081

A10BJ02

ATC

liraglutide; parenteral

2.4

19.7

137

583

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

19.6

197

975

L04AA01

ATC

[U] ciclosporin

3.3

19.4

220

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.1

19.3

193

953

G47.3

ICD-10 Finland

Sleep apnoea

1.4

19.3

1093

8365

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.7

19.3

163

FA1AC

NOMESCO Finland

Upper cavography

26.1

19.1

C01BC04

ATC

flecainide; systemic

2.1

18.8

180

876

WX213

NOMESCO Finland

Lower leg blockade

3.8

18.7

148

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

7.3

18.6

283

Kela drug reimbursment

Ivabradine

190.7

18.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

18.4

185

916

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.9

18.4

290

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

18.4

465

3030

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

25.1

18.2

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.3

18.2

137

605

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

18.1

600

4149

C01EB17

ATC

ivabradine; oral

52.7

17.9

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

33.0

17.9

XF406

NOMESCO Finland

High resolution ECG

33.0

17.9

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

17.7

478

7011

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

17.6

192

980

C02EA01, ,

ATC

3.1

17.5

239

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

17.5

504

3382

A10AB05

ATC

insulin aspart; parenteral

1.7

17.4

361

2238

A10BB12

ATC

glimepiride; oral

1.7

17.3

369

2305

B01AB04

ATC

dalteparin; parenteral

1.9

17.3

235

1291

WX900

NOMESCO Finland

Resuscitation

4.8

17.3

212

Kela drug reimbursment

Gout

2.3

17.2

132

587

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

17.2

190

974

FN1AD

NOMESCO Finland

CT of coronary arteries

2.7

17.2

329

L04AX01

ATC

azathioprine; systemic

2.0

17.2

175

871

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

17.2

1267

10085

SPAT1263

SPAT

Sampling

1.3

17.2

1706

14173

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

17.2

258

WX890

NOMESCO Finland

Intesive care monitoring

3.9

17.1

130

XX3BW, ,

NOMESCO Finland

31.6

17.0

M01AB05

ATC

diclofenac; systemic, rectal

0.8

17.0

2201

25153

E86

ICD-10 Finland

Volume depletion

2.3

16.9

130

579

4289X

ICD-9 Finland

Heart failure, unspecified

5.1

16.9

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

16.9

271

1567

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

16.8

143

664

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.5

16.8

169

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

16.8

178

899

I51.4

ICD-10 Finland

Myocarditis, unspecified

4.4

16.8

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

16.8

368

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

16.7

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

16.7

AQ2

Electrophysiological electroanatomical examination

4.2

16.7

102

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

15.1

16.6

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

16.5

116

497

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

7.3

16.5

AT7

Replacing the pacemaker VVI (R) S

27.6

16.5

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

27.6

16.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

16.5

186

961

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

23.1

16.4

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.5

16.3

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

16.3

285

1689

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

16.2

1254

10039

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.4

16.2

113

483

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.5

16.1

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

16.1

507

3467

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

16.1

647

4647

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

4.2

16.0

101

I20.00

ICD-10 Finland

Unstable angina

2.0

16.0

167

840

I95.2

ICD-10 Finland

Hypotension due to drugs

3.6

15.9

142

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

15.7

135

630

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

15.6

514

3545

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

15.6

302

1839

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

15.6

132

613

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

15.5

1266

10202

C02EA02, ,

ATC

1.8

15.5

229

1292

SPAT1255

SPAT

Intravenous administration of medicine

1.7

15.5

319

1976

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

15.5

190

1011

Z71.8

ICD-10 Finland

Other specified counselling

1.3

15.4

1127

8936

5CM18, ,

NOMESCO Finland

4.7

15.4

I40.0

ICD-10 Finland

Infective myocarditis

14.8

15.3

M01AC06

ATC

meloxicam; systemic, rectal

0.7

15.3

923

11758

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

5.0

15.2

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

15.2

283

1705

C08DB01

ATC

diltiazem; oral

1.8

15.2

250

1456

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.1

621

4473

B01AF03

ATC

edoxaban; oral

2.2

15.1

120

543

K28

ICPC

Limited function/disability (K)

2.2

15.0

120

545

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.9

1638

13724

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

14.9

226

1286

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

14.8

387

2537

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

14.8

197

1075

SPAT1325

SPAT

Vaccination

1.3

14.8

1433

11808

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.8

14.7

223

1267

R50.9

ICD-10 Finland

Fever, unspecified

1.4

14.7

632

4590

OAB43, ,

SPAT

0.6

14.7

340

5171

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

14.5

196

1075

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

11.9

14.5

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

3.0

14.5

207

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

3.4

14.5

156

XF620

NOMESCO Finland

Examination of circulation with color method

4.8

14.5

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

14.5

301

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

14.4

292

1799

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

2.5

14.4

348

J96.0

ICD-10 Finland

Acute respiratory failure

2.7

14.4

279

ZY000

NOMESCO Finland

Hospital inpatient

3.2

14.3

172

C07AB03

ATC

atenolol; systemic

1.7

14.3

276

1681

288

Kela drug reimbursment

Febuxostat

4.3

14.3

Z31.5

ICD-10 Finland

Genetic counselling

2.1

14.2

141

696

L04AD01

ATC

ciclosporin; systemic

2.6

14.1

328

TFN04, ,

NOMESCO Finland

3.9

14.1

102

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

6.4

14.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.7

13.9

267

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

13.9

1723

14627

FM1CD

NOMESCO Finland

Very extensive CT of heart

5.2

13.9

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

13.8

201

1129

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

13.8

197

1100

XG466

NOMESCO Finland

Sleep oxymetry

2.0

13.8

154

794

AR8

Catheter ablation of arrhythmia, target: left ventricular tachycardia

20.1

13.8

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

11.4

13.8

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

4.5

13.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.7

293

1833

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.6

251

1510

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

75.3

13.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.5

1535

12879

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

5.9

13.5

K60

ICPC

Cardiovascular, Result test/procedure

3.3

13.5

153

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

13.5

160

842

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.5

1218

9922

T86.2

ICD-10 Finland

Heart transplant failure and rejection

140.4

13.4

A10AC01

ATC

insulin (human); parenteral

1.6

13.4

333

2160

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

13.3

128

626

FM1EE, ,

SPAT

2.9

13.2

202

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.8

13.2

235

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.7

13.1

254

1547

M04AA03

ATC

febuxostat; oral

4.3

13.1

RS222, ,

NOMESCO Finland

3.0

13.0

193

3058, ,

Kela drug reimbursment

28.4

12.9

Q21.10

ICD-10 Finland

Persistent ostium secundum

6.1

12.9

160

Kela drug reimbursment

exenatide

2.3

12.9

442

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

3.8

12.9

100

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

12.7

903

7106

I24.0

ICD-10 Finland

Coronary thrombosis not resulting in myocardial infarction

9.7

12.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.0

12.6

186

N02AX02

ATC

tramadol; systemic, rectal

1.3

12.6

1884

16301

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

12.6

242

1473

FKC61

NOMESCO Finland

Repair of mitral valve insufficiency by a transluminally inserted clip

32.1

12.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

12.5

733

5602

FPJ11

NOMESCO Finland

Revision of biventricular CRT-P (VVIR) generator

130.3

12.4

AT6

Biventricular physiological heart failure pacemaker replacement DDD (R)

130.3

12.4

FJA00

NOMESCO Finland

Biopsy of right ventricle

130.3

12.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

4.2

12.4

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

13.2

12.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.4

1848

15973

I20.09

ICD-10 Finland

Unstable angina

1.6

12.4

288

1838

N02BE01

ATC

paracetamol; systemic, rectal

1.3

12.4

3972

37495

N18.0

ICD-10 Finland

End-stage renal disease

2.7

12.3

238

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

14.3

12.2

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.9

12.2

195

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.0

12.2

A07AA02

ATC

nystatin; oral

1.7

12.1

223

1341

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

4.5

12.1

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

12.1

133

683

ZXE90

NOMESCO Finland

More than 22 hours

3.5

12.1

119

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.4

12.0

129

Z2445

NOMESCO Finland

Psychologist

2.0

11.8

132

681

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

11.8

421

2947

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.8

11.8

215

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

11.7

1041

8436

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.7

1277

10623

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

11.7

131

677

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

11.7

359

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.9

11.7

189

S18

ICPC

Laceration/cut

1.2

11.6

1995

17474

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

30.1

11.6

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.4

11.6

122

ATA

Biventricular pacemaker replacement VVI (R) S

65.1

11.6

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

11.6

185

1070

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

22.9

11.6

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

9.2

11.5

Z94.3

ICD-10 Finland

Heart and lungs transplant status

+∞

11.5

354

Kela drug reimbursment

Ivabradine

+∞

11.5

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

11.5

413

ZXA05

NOMESCO Finland

Left side

1.3

11.4

1031

8370

ZXD00

NOMESCO Finland

Emergency procedure

1.9

11.3

137

727

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

11.3

384

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.9

11.3

141

757

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

9.6

11.2

JN4AD

NOMESCO Finland

Body CT examination

1.4

11.2

463

3333

E06.4

ICD-10 Finland

Drug-induced thyroiditis

17.1

11.2

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

3.9

11.1

R4120

NOMESCO Finland

Occupational therapy

1.6

11.1

256

1633

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

11.0

482

3504

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.7

10.9

213

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.5

10.9

284

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.2

10.8

800

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.7

10.8

209

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

10.7

477

3479

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

3.6

10.7

C01DX22

ATC

vericiguat; systemic

28.1

10.7

NHQ40

NOMESCO Finland

Amputation of toe

2.2

10.7

406

SPAT1285

SPAT

Provision of consultation response

1.7

10.6

209

1281

I45.2

ICD-10 Finland

Bifascicular block

3.5

10.6

100

K85

ICPC

Elevated blood pressure

0.7

10.5

350

4959

L28

ICPC

Limited function/disability (L)

1.3

10.5

726

5679

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

14.2

10.5

G04BD12

ATC

mirabegron; oral

0.6

10.5

243

3702

OAA67, ,

SPAT

0.6

10.4

159

2681

AM4

VAD (use of the left and / or right side mechanical support (other than IABP)

110.3

10.4

5244

FHL

Heart transplantation

110.3

10.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

10.3

303

2040

J01DA01

ATC

[U] cefalexin

1.2

10.2

2513

22733

SPAT1254

SPAT

Administration of medicine

1.4

10.2

585

4447

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

4.7

10.2

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

10.2

134

731

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

10.2

2880

26413

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.2

10.2

375

2BD01, ,

NOMESCO Finland

7.5

10.2

3A422, ,

NOMESCO Finland

13.1

10.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

10.1

125

669

A10AE05

ATC

insulin detemir; parenteral

1.6

10.1

228

1447

R03BA02

ATC

budesonide; inhalant

1.3

10.1

608

4660

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.6

10.0

211

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

10.0

119

629

J01FA06

ATC

roxithromycin; oral

1.2

10.0

1516

13050

TK830

NOMESCO Finland

Ultrafiltration

14.6

10.0

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.8

9.9

178

C10AA03

ATC

pravastatin; oral

1.5

9.9

315

2155

A12AA04

ATC

calcium carbonate; oral

2.3

9.9

334

J96.1

ICD-10 Finland

Chronic respiratory failure

2.0

9.9

106

540

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

9.9

425

J45.8

ICD-10 Finland

Mixed asthma

1.9

9.9

117

617

RS230, ,

NOMESCO Finland

3.6

9.9

A10BX07

ATC

[U] liraglutide

2.5

9.9

248

I48.4

ICD-10 Finland

Atypical atrial flutter

3.4

9.8

105

SPAT1260

SPAT

Consultation of another employee

1.3

9.8

671

5236

3AE00, ,

NOMESCO Finland

26.1

9.8

257, ,

Kela drug reimbursment

26.1

9.8

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.2

9.8

362

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

3.5

9.8

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

9.7

180

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

2.7

9.7

180

3025

Kela drug reimbursment

Calcium carbonate

3.5

9.7

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.2

9.7

121

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

9.7

362

2557

349

Kela drug reimbursment

Febuxostat

3.9

9.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

9.6

105

539

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.2

9.6

117

FM1BD

NOMESCO Finland

Extensive CT of heart

4.3

9.6

I45.3

ICD-10 Finland

Trifascicular block

3.3

9.6

102

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.2

9.5

366

G04CA01

ATC

alfuzosin; oral

0.7

9.5

478

6319

FN1BD

NOMESCO Finland

Extensive CT of coronary arteries

9.1

9.5

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

10.0

9.5

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

9.5

1015

12136

I11

ICD-10 Finland

Hypertensive heart disease

3.1

9.5

123

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

4.1

9.4

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

9.4

161

474, ,

NOMESCO Finland

17.5

9.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

9.4

277

1868

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

9.4

362

2574

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.4

1490

12870

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

9.4

300

4284

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

4.9

9.3

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

6.9

9.3

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

9.3

168

1009

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

9.2

287

1956

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.2

715

5675

162

Kela drug reimbursment

liraglutide

2.5

9.2

221

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

9.2

452

3355

OAA80, ,

SPAT

0.5

9.1

1811

M03BX02

ATC

tizanidine; oral

0.8

9.1

1943

21669

M10.2

ICD-10 Finland

Drug-induced gout

4.4

9.1

T82.7

ICD-10 Finland

Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts

4.8

9.1

ASX

Other pacemaker insertion

11.5

9.1

G71.08

ICD-10 Finland

Other muscular dystrophy

11.5

9.1

R11

ICD-10 Finland

Nausea and vomiting

1.5

9.0

283

1934

J46

ICD-10 Finland

Status asthmaticus

2.0

8.9

484

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

8.9

450

Z82.4

ICD-10 Finland

Family history of ischaemic heart disease and other diseases of the circulatory system

4.2

8.9

0034, ,

NOMESCO Finland

24.0

8.9

R03AC03

ATC

terbutaline; inhalant

1.4

8.9

457

3415

A41.8

ICD-10 Finland

Other specified sepsis

2.0

8.9

451

I44.4

ICD-10 Finland

Left anterior fascicular block

4.7

8.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

8.8

347

2477

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

8.8

206

1320

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

8.8

334

4625

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.9

8.8

103

543

B03XA02

ATC

darbepoetin alfa; parenteral

1.9

8.8

101

529

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

10.7

8.8

FM1AD

NOMESCO Finland

CT of heart

4.1

8.7

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

8.7

266

1808

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.3

8.7

289

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

8.7

174

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.6

781

6323

GBB00

NOMESCO Finland

Tracheostomy

2.4

8.6

234

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

2.7

8.6

169

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.6

855

7003

SPAT1252

SPAT

Overall medication plan or its review

1.5

8.6

282

1945

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.0

8.6

120

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.6

686

5467

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

8.6

131

751

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

4.0

8.5

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

3.8

8.5

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

8.5

108

585

205

Kela drug reimbursment

Chronic hypertension

1.2

8.5

1275

10930

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

4.2

8.4

A08

ICPC

Swelling

1.6

8.4

193

1230

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

8.4

168

2648

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

8.4

237

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.4

383

2806

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

2.9

8.4

127

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.2

8.4

294

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

4.9

8.4

EB1WA, ,

NOMESCO Finland

3.2

8.3

101

ZYC03

NOMESCO Finland

Remote contact, text-based

3.2

8.3

101

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

8.3

132

Kela drug reimbursment

Sarcoidosis

3.0

8.3

122

K08.3

ICD-10 Finland

Retained dental root

1.4

8.3

319

2266

J20

ICD-10 Finland

Acute bronchitis

1.4

8.3

338

2428

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

8.3

478

3636

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

3.6

8.3

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.2

8.3

289

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

8.2

172

1073

RS220, ,

NOMESCO Finland

2.4

8.1

210

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.8

8.1

122

696

I49.2

ICD-10 Finland

Junctional premature depolarization

4.5

8.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

8.1

221

1468

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

11.7

8.1

FWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of heart and major thoracic vessels

11.7

8.1

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

11.7

8.1

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.4

8.1

217

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

8.0

517

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

10.0

8.0

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

8.0

290

2039

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

8.0

497

AA1

Conventional CABG

1.8

8.0

107

590

A28

ICPC

Limited function/disability NOS

1.3

7.9

719

5817

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.9

370

2721

D01BA02

ATC

terbinafine; oral

0.8

7.9

776

9402

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.3

7.9

FM1DE, ,

SPAT

3.3

7.9

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.0

7.9

395

SPAT1251

SPAT

Organisation of medication

1.7

7.9

133

785

K06.18

ICD-10 Finland

Another gingival hyperplasia

3.9

7.9

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

7.8

102

557

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

0.4

7.8

898

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.8

299

2126

FM2CE, ,

NOMESCO Finland

6.9

7.8

G71.0

ICD-10 Finland

Muscular dystrophy

45.0

7.7

SPAT1281

SPAT

Other administrative function

1.4

7.7

280

1970

R06.2

ICD-10 Finland

Wheezing

1.6

7.7

152

935

D75.1

ICD-10 Finland

Secondary polycythaemia

2.9

7.7

117

130

Kela drug reimbursment

Malignant tumour

0.7

7.7

213

3127

J01CF05

ATC

flucloxacillin; systemic

1.5

7.7

227

1534

R02

ICD-10 Finland

Gangrene, not elsewhere classified

4.0

7.6

R57.0

ICD-10 Finland

Cardiogenic shock

8.0

7.6

AT8

Physiological pacemaker replacement DDD (R) S

25.0

7.6

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.0

7.5

395

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

3.8

7.5

K22

ICPC

Risk factor cardiovascular disease

1.5

7.5

243

1673

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

4.2

7.5

J01AA02

ATC

doxycycline; systemic

1.2

7.4

3300

31061

Heart transplantation

80.2

7.4

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.3

7.4

220

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.6

7.4

148

OAB48, ,

SPAT

0.6

7.3

155

2409

3A560, ,

NOMESCO Finland

8.4

7.3

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

7.3

167

1066

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

7.3

FM1DP

NOMESCO Finland

Heart, metabolic PET

+∞

7.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

7.3

595

4750

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.3

2703

25034

ECB00

NOMESCO Finland

Suture of gingiva

1.7

7.3

141

864

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.1

7.2

299

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

7.2

1990

17978

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

2.7

7.2

144

X57

ICD-10 Finland

Unspecified privation

1.9

7.2

458

TGC00

NOMESCO Finland

Bronchial lavation

1.8

7.2

109

625

GD2SN

NOMESCO Finland

Lung ventilation SPECT

2.7

7.2

133

I42.4

ICD-10 Finland

Endocardial fibroelastosis

30.0

7.1

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

3.6

7.1

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.7

7.1

131

792

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

7.9

7.1

J01MA01

ATC

ofloxacin; systemic

1.4

7.1

330

2428

ZXC96

NOMESCO Finland

Robot assisted procedure

0.4

7.1

756

C09DA01

ATC

losartan and diuretics; oral

0.7

7.0

243

3422

C08CA01

ATC

amlodipine; oral

0.8

7.0

1371

15530

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

7.0

225

1547

N05CD07

ATC

temazepam; oral

1.3

7.0

458

3549

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

7.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.2

7.0

258

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

6.9

226

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.9

107

618

M01AE02

ATC

naproxen; oral, rectal

0.8

6.9

1746

19353

ZXD35

NOMESCO Finland

Usual procedure

1.7

6.9

121

724

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.9

141

878

SPAT1060

SPAT

Administration of oxygen

3.1

6.8

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

6.8

286

AR5

Catheter ablation of arrhythmia, target: atrial flutter

3.3

6.8

I45.6

ICD-10 Finland

Pre-excitation syndrome

3.3

6.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.7

6.8

113

665

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

6.8

110

643

H02AB04

ATC

methylprednisolone; systemic

1.3

6.7

504

3977

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

2.8

6.7

115

S76

ICPC

Skin infection other

1.5

6.7

201

1363

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.7

1350

11858

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

22.5

6.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

6.7

104

602

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

6.6

199

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

0.5

6.6

1289

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

3.6

6.6

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

6.6

186

1247

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.3

6.5

213

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.6

6.5

140

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

6.5

427

5441

221

MVR mechanical

69.9

6.4

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

69.9

6.4

F1279, ,

NOMESCO Finland

7.4

6.4

3A077, ,

NOMESCO Finland

7.4

6.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

2.8

6.4

113

WW500

NOMESCO Finland

Blood transfusion

1.6

6.4

157

1022

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.1

6.3

275

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

6.5

6.3

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

9.3

6.3

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

6.3

1150

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

6.3

222

1558

N178, I420,

ICD-10 Finland

+∞

6.2

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.8

6.2

384

4941

SPAT1301

SPAT

No procedures

1.2

6.2

1212

10602

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

2.8

6.2

109

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

6.2

388

A98

ICPC

Health maint/preventive medicine

0.8

6.2

4076

42026

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

2.7

6.2

115

K92.1

ICD-10 Finland

Melaena

1.4

6.2

229

1621

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

6.2

273

3685

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.1

6.1

245

ZZA00

NOMESCO Finland

Split skin graft

1.6

6.1

119

731

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.1

432

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

6.1

174

1168

A49

ICD-10 Finland

Bacterial infection of unspecified site

3.4

6.1

SPAT1211

SPAT

Application of soft bandage

1.4

6.1

310

2314

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

2.0

6.1

334

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.2

6.1

207

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

1.8

6.1

426

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

6.1

501

4003

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

2.8

6.1

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

12.5

6.1

Z94.0

ICD-10 Finland

Kidney transplant status

2.3

6.1

201

RS121, ,

NOMESCO Finland

3.0

6.1

A10BJ05

ATC

dulaglutide; parenteral

1.8

6.1

434

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

6.0

105

2AX04, ,

NOMESCO Finland

10.0

6.0

114

Kela drug reimbursment

Glaucoma

0.7

6.0

182

2625

B01AC24

ATC

ticagrelor; oral

0.5

6.0

1174

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.1

6.0

254

V03AE01

ATC

polystyrene sulfonate; oral

2.0

6.0

315

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027456) Digoxin [Moles/volume] in Serum or Plasma

528

867

6.71

312.15

3.1

3.0

0.81

0.83

nmol/l

0.40

407

643

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2002

6273

4.72

307.65

3.4

2.6

2.33

2.26

g/l

7.50

1912

5819

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3599

13179

7.64

307.65

8.3

3.0

2678.84

1611.62

ng/l

21.13

3450

11367

(3022948) Iron [Moles/volume] in Serum or Plasma

2076

6719

4.64

307.65

3.4

2.6

13.60

12.68

umol/l

5.90

1992

6270

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1552

3985

5.25

307.65

6.0

2.8

433.17

207.19

ng/l

29.34

1502

3634

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1969

5929

4.90

307.65

3.5

2.7

22.97

22.77

0.25

1779

5046

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2649

15234

2.62

232.35

3.9

2.8

186.93

171.97

ug/l

0.73

2528

13914

(3022217) INR in Platelet poor plasma by Coagulation assay

3288

21007

2.74

232.00

40.8

17.3

1.65

1.35

inr

38.34

1010

5981

(3020779) Urea [Moles/volume] in Serum or Plasma

1154

4396

3.13

224.03

17.1

7.6

12.40

10.51

mmol/l

12.24

1107

4180

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

488

1020

5.21

221.74

1.9

10.72

11.58

mg/l

1.36

446

946

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2013

10532

2.55

209.58

2.8

2.2

3.03

3.00

mg/l

0.20

1808

8928

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1524

7150

2.65

196.82

7.5

3.4

0.82

0.81

mmol/l

1.09

1447

6712

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

605

1770

3.76

176.36

4.2

3.3

4.20

4.44

pmol/l

5.49

561

1553

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

560

1657

3.69

159.94

1.9

1.8

30.90

38.70

u/l

10.89

368

1441

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1638

8629

2.35

158.50

6.3

4.0

539.32

591.39

ng/l

0.12

1532

7262

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

560

1744

3.50

147.53

6.2

3.0

0.36

0.33

u/ml

1.12

351

996

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1227

5924

2.43

142.39

8.6

6.4

1.11

1.03

mmol/l

13.69

1157

5531

(3000991) Gas panel - Venous blood

882

3918

2.53

120.61

15.8

8.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2445

16589

1.95

110.66

6.1

3.9

103.45

62.78

ng/l

0.44

2050

12464

(3026250) Tacrolimus [Mass/volume] in Blood

139

180

7.92

100.78

36.9

35.3

7.85

7.25

ug/l

2.74

130

163

(3042733) HLA Ab [Presence] in Serum

122

136

9.18

99.80

4.6

4.7

—

(3002032) Base excess in Venous blood by calculation

894

4341

2.30

98.43

6.1

4.0

1.69

1.88

mmol/l

0.68

753

3622

(3021447) Carbon dioxide [Partial pressure] in Venous blood

890

4349

2.28

96.34

6.1

4.0

5.87

5.83

kpa

0.68

860

4213

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1048

5490

2.16

95.41

13.2

7.4

4.98

5.08

kpa

2.40

992

5239

(3027801) Oxygen [Partial pressure] in Arterial blood

1047

5489

2.16

95.09

13.2

7.4

10.99

12.08

kpa

13.73

988

5238

(3012544) pH of Venous blood

910

4511

2.25

95.05

6.3

4.0

7.38

7.37

—

(3003396) Base excess in Arterial blood by calculation

1043

5477

2.15

94.24

13.2

7.5

0.74

1.01

mmol/l

1.05

823

4321

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

550

2203

2.69

91.49

6.9

4.2

23.81

24.03

mmol/l

0.78

540

2149

(3023368) Bacteria identified in Blood by Culture

1926

12663

1.86

90.28

5.9

4.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

855

4263

2.22

87.39

3.4

2.4

18.87

7.78

ug/l

6.50

793

3737

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2861

21474

1.81

84.54

9.9

6.6

15.09

12.44

umol/l

14.62

2755

20472

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2578

18767

1.79

84.45

11.5

6.5

1.19

1.20

mmol/l

17.85

2425

17142

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2770

20601

1.80

84.34

12.1

7.4

1.19

1.21

mmol/l

24.29

2386

17543

(3016502) Oxygen saturation in Arterial blood

949

4993

2.12

84.31

14.2

7.7

94.59

95.46

2.62

920

4804

(3014111) Lactate [Moles/volume] in Serum or Plasma

814

4087

2.19

81.28

14.6

7.3

1.53

1.39

mmol/l

2.21

782

3972

(3018418) pH of Serum or Plasma

1806

12066

1.79

77.13

5.5

4.3

7.40

0.60

373

2350

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

351

1212

3.04

76.58

6.0

2.7

3.74

3.57

g/l

1.12

336

1158

(3013826) Glucose [Moles/volume] in Serum or Plasma

3141

24704

1.76

74.29

9.8

5.1

7.04

6.88

mmol/l

3.34

3027

23386

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

565

2527

2.40

73.80

17.9

9.7

24.03

24.22

mmol/l

0.58

541

2449

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1211

7313

1.87

70.91

2.1

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1350

8445

1.83

70.53

6.0

1.7

1.57

1.39

mg/l

0.88

1089

6577

(3001604) Monocytes [#/volume] in Blood

2630

19886

1.70

69.68

8.1

5.9

0.65

0.62

e9/l

5.30

2298

17102

(3022493) Free Hemoglobin [Mass/volume] in Plasma

115

182

6.45

69.46

39.4

3.5

77.04

70.71

mg/l

0.23

102

127

(3042936) Bacteria identified in Isolate by Culture

1061

6176

1.92

69.39

2.7

2.1

—

(3006315) Basophils [#/volume] in Blood

2632

19948

1.70

68.74

8.1

5.9

0.04

e9/l

0.55

2299

17156

(3013115) Eosinophils [#/volume] in Blood

2694

20571

1.69

68.17

8.7

6.1

0.19

0.20

e9/l

3.00

2364

17897

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

960

5449

1.95

67.48

9.3

4.3

261.88

242.33

u/l

2.73

911

5142

(3002173) Hemoglobin [Mass/volume] in Arterial blood

840

4555

2.02

67.32

15.6

8.2

124.11

121.90

g/l

2.11

826

4431

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

504

2234

2.40

66.89

1.8

1.7

1.55

1.54

g/l

0.04

436

1918

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

406

1630

2.63

66.51

4.7

2.3

928.68

618.27

ug/l

0.35

393

1550

(3019198) Lymphocytes [#/volume] in Blood

2667

20393

1.68

66.38

8.2

6.0

1.76

1.91

e9/l

2.14

2356

17914

(3024932) HLA-DR beta [Type]

132

7.40

66.04

1.0

1.1

—

(3024471) HLA-A [Type]

134

7.29

65.17

1.0

—

(3021589) Normoblasts [#/volume] in Blood

2346

17409

1.67

64.98

14.3

10.4

0.00

e9/l

0.56

1952

14239

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

135

7.23

64.74

2.6

2.0

191.63

166.11

1.69

129

(3024561) Albumin [Mass/volume] in Serum or Plasma

2425

18170

1.67

64.54

5.8

5.3

33.99

35.00

g/l

14.03

2291

16916

(40758558) Short blood count panel - Blood

1503

9934

1.74

63.89

9.5

6.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1151

7085

1.82

62.18

6.3

2.1

32.52

30.14

19.51

1124

6880

(3022096) Basophils/100 leukocytes in Blood

2413

18167

1.65

62.14

8.5

6.2

0.63

0.66

2.68

2316

16915

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

890

5054

1.93

61.93

2.0

1.8

—

(3036489) Thrombin time

374

1497

2.62

61.53

6.0

2.2

22.73

21.75

1.02

360

1345

(3006504) Eosinophils/100 leukocytes in Blood

2461

18714

1.64

60.16

8.5

6.2

2.69

2.91

4.99

2365

17432

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

881

5049

1.91

59.39

1.9

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

2466

18818

1.63

58.98

8.7

6.5

9.11

8.94

2.04

2374

17557

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

159

388

4.20

58.73

1.4

1.1

87.65

96.80

3.05

159

362

(3014148) Varicella zoster virus Ab [Titer] in Serum

146

334

4.48

58.62

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

2504

19229

1.62

57.98

8.6

6.3

23.60

26.59

34.40

2411

17970

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

11.02

57.26

1.5

1.3

4.19

397880.72

nmol/l

0.49

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

146

347

4.31

55.83

2.3

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1800

12828

1.64

55.81

3.6

3.3

48.09

37.18

u/l

1.21

1706

12136

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

143

337

4.34

55.28

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

214

667

3.31

55.27

1.5

1.3

289.83

271.65

u/ml

0.41

160

407

(3033658) Prothrombin time (PT) actual/Normal

1543

10602

1.67

55.07

6.7

4.3

69.48

85.38

75.18

1508

10373

(3026493) Urate [Moles/volume] in Serum or Plasma

1668

11721

1.64

54.35

3.6

2.9

2892.17

4979.44

umol/l

1.67

1473

10199

(3018010) Neutrophils/100 leukocytes in Blood

2454

18939

1.60

54.21

8.4

6.0

60.87

58.04

26.24

2358

17692

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

183

527

3.57

53.47

1.5

1.2

3.14

4.51

u/ml

1.13

241

(40760892) CBC W Ordered Manual Differential panel - Blood

2428

18731

1.59

53.42

8.7

6.6

—

(3044889) 12 lead EKG panel

3426

28722

1.65

53.01

7.6

4.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

185

541

3.52

52.81

1.5

1.2

3.30

3.24

u/ml

0.02

167

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

196

5.40

52.46

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

220

725

3.13

51.80

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

213

691

3.18

51.49

1.7

1.5

125.09

118.00

u/ml

0.31

141

(3024354) Oxygen [Partial pressure] in Venous blood

653

3538

1.98

51.42

5.3

3.4

4.55

4.60

kpa

0.21

622

3414

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

147

378

3.98

50.59

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

229

785

3.01

50.36

1.6

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

698

3910

1.92

49.69

2.0

2.6

64.20

66.21

g/l

8.96

650

3550

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

175

514

3.49

49.62

1.4

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

102

7.25

49.51

1.2

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

9.61

49.50

1.6

1.2

82.27

78.68

0.28

(3023183) Ammonium ion [Moles/volume] in Plasma

273

1050

2.70

48.46

2.5

2.7

31.44

34.86

umol/l

1.33

246

938

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

709

4029

1.89

48.21

2.2

2.3

0.20

0.21

g/l

3.13

648

3738

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

201

657

3.15

47.97

9.4

6.6

11.07

11.87

mg/l

1.63

181

602

(3010375) cycloSPORINE [Mass/volume] in Blood

193

5.16

47.09

20.9

26.5

114.64

116.66

ug/l

0.09

159

(3013650) Neutrophils [#/volume] in Blood by Automated count

2823

22927

1.55

46.84

11.0

9.2

4.53

4.28

e9/l

5.87

2486

19933

(3045788) Cell count panel - Pleural fluid

164

480

3.50

46.75

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

181

574

3.24

45.43

1.4

32807.79

61487.09

e6/l

1.09

115

342

(3023199) Leukocytes [#/volume] in Pleural fluid

191

631

3.11

44.76

1.5

6344.14

1979.10

e6/l

0.41

133

451

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.94

43.67

1.5

1.2

79.83

78.12

0.10

(3007853) Bacteria identified in Skin by Aerobe culture

807

4922

1.77

43.16

2.3

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

501

2642

2.00

42.20

21.0

10.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

244

952

2.65

42.05

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

174

567

3.15

41.74

1.4

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3587

31104

1.58

41.50

11.5

7.9

82.69

79.80

u/l

2.43

3450

29351

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

765

4687

1.75

40.01

2.7

2.9

10.21

9.42

umol/l

0.58

691

4161

(3003434) Protein [Mass/volume] in Pleural fluid

200

729

2.82

39.32

1.5

26.03

32.38

g/l

9.35

164

656

(3027945) Reticulocytes/100 erythrocytes in Blood

857

5444

1.70

39.25

2.7

2.6

1.88

1.76

2.81

773

4777

(3019060) Gas panel - Arterial blood

571

3234

1.87

38.71

6.3

4.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

223

882

2.60

37.38

10.3

5.9

1303.46

3232.36

iu/ml

0.47

137

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

543

3083

1.86

36.42

1.7

—

(3034426) Prothrombin time (PT)

123

5.59

35.91

1.6

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

278

1246

2.31

35.46

5.6

3.3

—

(3024928) Oxygen saturation in Venous blood

233

979

2.45

34.38

6.2

3.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1709

13055

1.48

34.16

2.9

2.2

268.67

238.43

u/l

0.46

1634

12222

(3021879) Hepatitis B virus core Ab [Presence] in Serum

442

2418

1.91

33.16

1.5

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

119

356

3.40

32.84

3.2

2.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.41

32.63

1.3

1.2

44.57

94.75

ng/l

0.60

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

225

953

2.43

32.62

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

225

953

2.43

32.62

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

289

1367

2.18

32.34

1.7

1.8

—

(3051651) Icteric interference index of Serum or Plasma

239

3.95

32.10

8.6

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

613

3755

1.72

31.56

1.8

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

646

4015

1.70

31.54

1.8

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

253

1150

2.27

31.20

4.7

3.4

8.09

8.00

kpa

0.41

248

1121

(3030467) Casts [#/volume] in Urine by Automated count

1571

12012

1.45

30.37

3.5

3.4

0.87

0.45

e6/l

2.02

1250

9295

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

4.81

30.35

1.9

2.3

5422.35

18537.99

e6/l

0.53

(3002582) Erythrocytes [#/volume] in Urine

1701

13208

1.44

30.26

3.6

3.5

101.37

95.18

e6/l

0.09

1367

10347

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

226

992

2.34

30.24

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

512

3023

1.78

29.93

5.3

4.3

133.61

99.24

ng/l

7.27

464

2615

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

502

2949

1.78

29.86

5.0

3.8

2.00

1.68

mmol/l

0.96

360

2155

(36304419) Bacteria [Presence] in Urine

1516

11552

1.45

29.69

3.5

3.4

—

(40768806) Pleura Pathology biopsy report

154

569

2.76

29.54

1.4

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

521

3107

1.76

29.40

5.1

3.8

5.12

5.14

kpa

0.17

499

2944

(46235355) HIV 1 and 2 tests - Meaningful Use set

736

4818

1.62

29.22

1.9

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

482

2840

1.77

28.32

5.4

3.5

129.78

128.95

g/l

0.30

465

2767

(3009343) pH of Capillary blood

511

3062

1.75

28.32

5.0

3.9

7.40

7.41

0.89

373

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

604

3795

1.68

28.12

2.4

2.5

38.55

51.89

u/l

0.52

520

3274

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

463

2707

1.79

27.92

1.8

1.7

—

(1616796) Gas panel - Central venous blood

234

1081

2.22

27.75

4.2

4.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

505

3041

1.74

27.47

9.7

7.1

24.12

24.48

mmol/l

1.17

481

2897

(3023487) Leukocytes [#/volume] in Peritoneal fluid

161

4.33

27.13

2.1

2.5

575.69

5055.57

e6/l

0.51

123

(3018095) Leukocytes [#/volume] in Urine

1845

14764

1.40

26.81

4.1

4.0

87.38

94.90

e6/l

0.15

1413

10954

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3134

27397

1.40

26.78

4.6

3.5

15.51

14.90

pmol/l

27.04

2901

24560

(3027273) Bicarbonate [Moles/volume] in Venous blood

401

2279

1.83

26.53

4.3

3.7

24.74

25.11

mmol/l

1.18

384

2202

(3006184) Hemoglobin [Mass/volume] in Capillary blood

227

1059

2.20

26.28

2.6

2.2

130.96

129.70

g/l

0.27

156

766

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

228

1066

2.19

26.25

1.4

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

136

503

2.75

26.07

1.3

1.4

6.88

6.31

mmol/l

1.16

127

466

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

249

1209

2.12

26.04

1.3

13.54

14.53

iu/ml

—

(40767503) Oxygen content in Capillary blood by calculation

220

1022

2.21

25.74

3.0

2.6

16.27

16.15

0.15

121

545

(3000850) Epithelial cells [#/volume] in Urine

1232

9229

1.45

25.69

2.8

4.41

3.98

e6/l

0.72

1136

8305

(3010421) pH of Blood

251

1229

2.10

25.68

4.6

4.8

7.42

0.01

221

1104

(3012501) Base excess in Blood by calculation

223

1055

2.17

24.93

4.7

4.9

2.40

2.54

mmol/l

0.30

137

716

(3037522) Nuclear Ab [Titer] in Serum

703

4728

1.57

24.58

1.3

422.91

474.74

titre

0.32

117

943

(3021901) Oxygen saturation in Capillary blood

202

931

2.22

24.10

3.5

2.9

—

(3023520) Reticulocytes [#/volume] in Blood

625

4137

1.59

23.34

2.8

2.6

74.14

68.52

e9/l

2.57

464

3184

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

317

3.10

23.27

1.1

1.2

107.69

108.24

titre

0.01

(3051611) Lipemic interference index of Serum or Plasma

113

411

2.79

22.40

7.6

3.2

—

(3033799) Differential panel - Peritoneal fluid

146

4.15

22.38

2.4

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

430

2653

1.68

21.22

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1280

9945

1.39

20.96

3.2

2.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

115

4.38

20.09

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1539

18713

0.74

20.05

3.7

4.4

23.14

21.95

2.14

711

9411

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

243

1287

1.93

19.98

1.2

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1597

12932

1.35

19.93

3.3

2.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

276

1526

1.86

19.89

2.3

3.4

43.54

60.09

mg/l

0.84

220

1239

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

232

1212

1.96

19.86

4.7

3.5

1.97

1.63

mg/l

6.48

216

1108

(3034860) Kappa light chains.free [Mass/volume] in Serum

276

1527

1.86

19.85

2.3

3.4

52.78

58.48

mg/l

0.47

221

1238

(3026782) Osmolality of Urine

1144

8801

1.39

19.67

3.0

3.1

522.32

563.53

mosm/kgh2o

10.48

1011

7583

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

1703

1.81

19.57

1.8

2.4

3.14

2.94

g/l

2.44

271

1531

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1363

1.90

19.45

1.8

2.3

0.00

0.04

g/l

2.52

230

1245

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

349

2083

1.73

19.44

2.3

1.9

6.00

2.52

ug/l

0.41

316

1833

(3026692) Albumin [Mass/volume] in Peritoneal fluid

131

4.08

19.40

1.4

1.7

18.70

13.67

g/l

3.78

101

(3020891) Body temperature

324

1895

1.76

19.38

5.8

4.9

—

(21494755) Public health laboratory ask at order entry panel

125

2772

0.44

19.29

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

1719

1.79

19.25

1.7

2.4

10.00

10.25

g/l

0.45

269

1536

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2002

23354

0.76

19.08

4.1

5.1

2.74

3.32

ug/l

0.89

1761

20940

(1761868) Lipid panel - Serum or Plasma

1009

12996

0.72

18.72

3.3

3.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1258

1.91

18.72

1.8

2.3

0.00

g/l

-0.00

214

1161

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1836

1.75

18.53

1.7

2.3

3.65

3.71

g/l

0.42

284

1663

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

267

1495

1.83

18.48

2.3

3.4

2.04

2.78

ratio

0.40

115

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1839

1.75

18.43

1.7

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1839

1.75

18.43

1.7

2.3

7.32

7.35

g/l

0.10

284

1664

(3044007) Cell count panel - Peritoneal fluid

128

4.02

18.31

2.4

2.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

124

524

2.40

18.18

1.3

568.49

363.86

u/l

0.23

118

499

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

236

1280

1.89

18.07

1.8

2.3

0.00

g/l

0.50

214

1165

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

253

1410

1.84

17.79

1.8

2.2

35.60

37.57

g/l

4.66

222

1237

(3035880) pH of Pleural fluid

302

2.85

17.68

1.2

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1581

12969

1.32

17.52

3.1

2.6

60.90

67.88

u/l

0.52

1494

12051

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

686

2.19

17.49

4.1

2.9

6045.45

2295.67

u/ml

0.29

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

136

2816

0.47

17.42

1.6

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

187

949

2.01

17.41

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

641

4532

1.48

17.33

4.6

3.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

204

1069

1.95

17.33

1.6

1.8

—

(3012516) Albumin [Mass/volume] in Urine

1641

13553

1.32

17.26

3.4

3.3

165.65

365.32

mg/l

2.63

1205

9060

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

210

1116

1.92

17.12

1.6

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

269

1549

1.78

16.98

1.8

2.4

0.38

1.09

g/l

4.68

234

1329

(3009508) Creatinine [Moles/volume] in Urine

1682

13968

1.31

16.92

3.4

3.3

7.26

7.96

mmol/l

10.72

1436

11667

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

179

908

2.01

16.70

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

287

1705

1.73

16.25

2.6

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1249

9990

1.34

16.24

1.7

1.6

19.00

19.64

nmol/l

0.85

1133

8546

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.99

16.03

2.2

2.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

191

1010

1.93

15.82

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

478

3250

1.52

15.57

1.9

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1700

14264

1.29

15.46

4.0

3.9

13.00

9.45

mg/mmol

1.85

1214

9365

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

912

7000

1.37

15.41

3.1

3.2

2.18

1.44

e6/l

1.74

494

3987

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

248

2.89

15.28

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

190

1016

1.91

15.23

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

115

511

2.28

15.10

1.5

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

110

3.94

15.09

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

958

7436

1.36

15.04

3.0

1.31

1.05

e6/l

0.90

539

4392

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

217

1220

1.82

14.86

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

1005

1.90

14.77

1.3

1.2

—

(3022313) Gas panel - Capillary blood

348

2233

1.60

14.63

5.4

4.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

144

711

2.06

14.51

1.6

1.7

77.01

4.41

iu/l

0.48

219

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

1083

1.85

14.51

1.4

1.5

1.19

1.18

g/l

0.21

182

1025

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

402

2.42

14.44

1.2

1.3

12.27

13.45

u/l

0.09

372

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

190

1045

1.85

13.98

1.4

1.5

0.24

g/l

0.06

174

991

(3021788) Differential panel - Synovial fluid

150

766

1.99

13.79

1.4

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.00

13.33

1.1

58.46

82.67

3.22

(40760888) Immunoglobulin light chains.free panel - Serum

203

1171

1.77

12.79

2.3

3.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

157

837

1.90

12.75

1.2

1.3

17.90

41.81

u/l

4.52

142

724

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

130

651

2.02

12.65

1.5

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2843

25747

1.25

12.65

4.8

4.5

1206.49

1383.16

e6/l

0.06

422

(3013512) EKG study

1488

12517

1.27

12.64

6.9

4.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

151

798

1.92

12.60

1.3

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

814

1.91

12.51

1.6

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.89

12.51

1.1

1.3

48.04

80.08

4.40

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1783

0.44

12.51

1.4

1.5

—

(3026008) Bacteria identified in Urine by Culture

1364

11374

1.28

12.40

2.9

3.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

142

751

1.92

11.84

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

142

751

1.92

11.84

1.6

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

142

3.19

11.62

6.7

7.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2133

18841

1.24

11.44

3.3

2.7

—

(3025941) Bacteria identified in Stool by Culture

295

1941

1.55

11.15

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

472

3417

1.42

11.08

3.3

2.7

52.79

64.21

ml/min/173m2

10.04

231

1378

(3015377) Calcium [Moles/volume] in Serum or Plasma

1562

13373

1.25

11.07

3.5

2.33

2.35

mmol/l

3.44

1367

11701

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1952

17152

1.23

10.80

2.2

2.0

92.49

92.82

pmol/l

0.11

1115

9376

(3038071) Oxygen [Partial pressure] in Mixed venous blood

123

3.27

10.79

6.2

7.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

344

2364

1.49

10.61

1.6

1.9

1.17

1.37

g/l

0.93

323

2141

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

652

1.93

10.57

1.3

1.5

—

(3000492) Spirometry study

504

3730

1.39

10.40

1.6

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

228

1438

1.61

10.34

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

178

1053

1.72

10.32

1.1

1.2

68.89

146.93

titre

1.50

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3675

34580

1.26

10.23

5.5

4.3

2.14

2.11

mu/l

0.15

3428

31171

(3005719) IgG [Mass/volume] in Serum or Plasma

418

3022

1.42

9.88

2.6

2.7

10.61

10.53

g/l

0.15

395

2750

(3019309) Folate [Moles/volume] in Red Blood Cells

1008

8296

1.27

9.85

1.8

1249.46

1158.02

nmol/l

2.17

799

6198

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

101

508

2.01

9.81

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

101

508

2.01

9.81

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1134

13420

0.80

9.73

2.7

3.1

0.80

0.78

ug/l

0.15

817

9165

(3013707) Erythrocyte sedimentation rate by Westergren method

3118

28901

1.22

9.63

5.2

4.1

15.40

12.76

mm/h

14.15

2917

26639

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4073

38931

1.28

9.14

28.8

16.3

25.69

26.85

mg/l

1.55

3660

31513

(3047181) Lactate [Moles/volume] in Blood

231

1509

1.56

9.06

8.9

6.2

1.50

1.33

mmol/l

0.98

206

1336

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

460

3431

1.38

9.04

4.8

4.3

1.21

1.22

mmol/l

4.22

430

3020

(3039443) Prostate specific Ag panel - Serum or Plasma

1223

0.44

8.89

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

161

2.75

8.85

1.1

254.73

210.60

iu/ml

0.22

161

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

127

716

1.79

8.76

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

118

651

1.83

8.74

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

286

1971

1.48

8.73

7.6

5.3

1.72

1.65

0.61

270

1844

(44816559) Phosphatidylethanol [Mass/volume] in Blood

124

695

1.80

8.72

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

640

1.82

8.30

1.3

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

453

3419

1.36

8.26

2.3

391.83

368.59

nmol/l

1.56

429

3142

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

276

1914

1.47

8.18

6.1

4.2

24.70

mmol/l

0.00

261

1757

(3035947) Staphylolysin Ab [Units/volume] in Serum

228

2.38

8.14

1.2

1.1

3.50

iu/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

279

1942

1.46

8.11

7.7

5.4

0.86

0.88

0.34

262

1819

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.91

8.02

2.9

6.7

—

(3002385) Erythrocyte distribution width [Ratio]

3495

32989

1.21

8.01

34.6

19.2

15.35

15.29

0.14

3447

32362

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

227

2.35

7.76

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

227

2.35

7.76

1.3

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

118

677

1.76

7.72

3.5

3.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

174

2.54

7.65

1.9

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

270

1895

1.45

7.54

2.2

2.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

3.81

7.51

1.5

1.4

66.75

74.14

0.40

(3006576) Bicarbonate [Moles/volume] in Blood

183

2.47

7.39

6.0

7.6

25.71

24.68

mmol/l

0.97

165

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

489

1.88

7.38

3.6

3.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

221

2.32

7.30

1.1

1.2

38.95

21.68

u/l

2.50

184

(3044941) Cell count panel - Synovial fluid

117

682

1.73

7.27

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

164

1044

1.59

7.26

1.7

1.6

16728.35

16905.69

e6/l

0.01

112

749

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

172

1108

1.57

7.24

1.5

1.6

—

(3019977) pH of Arterial blood

275

2.16

7.11

2.5

2.4

7.42

0.01

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

526

1.82

7.04

1.3

1.6

66.30

61.28

0.57

339

(3017569) Oxygen content in Arterial blood

244

2.23

7.02

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

312

2.07

6.88

1.1

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

246

1740

1.44

6.62

2.0

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

375

1.93

6.47

1.4

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

1254

0.53

6.46

1.1

—

(4200892) Spirometry reversibility

378

2892

1.33

6.32

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

115

695

1.67

6.32

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.94

6.29

1.1

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

232

2.17

6.14

1.1

1.2

135.32

94.74

u/l

1.55

196

(3042631) Mycobacterium sp identified in Specimen

113

690

1.65

5.99

2.1

2.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

229

2.15

5.93

2.2

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

252

2.07

5.74

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.15

5.73

1.3

1.2

93.27

457.04

u/l

0.40

(3004451) EKG impression Narrative

240

2.09

5.67

1.1

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

223

2.12

5.50

16.5

11.8

—

(3000494) Fungus identified in Specimen by Culture

582

4792

1.24

5.48

1.7

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

2.62

5.46

1.2

1.6

—

(40768800) Prostate Pathology biopsy report

1506

0.61

5.33

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

559

4596

1.24

5.33

1.8

1.66

1.55

2.14

465

3954

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

161

1098

1.48

5.31

4.6

1.7

8.26

4.08

mg/l

2.53

146

805

(3017446) Testosterone [Moles/volume] in Serum or Plasma

355

4514

0.77

5.28

2.4

2.2

11.80

12.92

nmol/l

1.74

311

3995

(4035726) Immunohistochemistry procedure

445

3568

1.27

5.27

2.2

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4205

40829

1.22

5.25

40.4

19.1

139.35

139.65

mmol/l

11.82

4145

39852

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

492

1.72

5.24

1.7

1.8

—

(4281824) Cell count and differential, peritoneal fluid

290

1.94

5.19

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

539

1.68

5.19

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

464

1.74

5.18

1.7

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

116

742

1.58

5.15

1.1

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

224

2.06

5.06

1.3

1.4

56.44

65.87

0.82

179

(3040151) Glucose [Moles/volume] in Capillary blood

530

1.67

4.98

9.0

21.0

7.02

7.43

mmol/l

0.80

445

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

425

1.75

4.97

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

135

2.38

4.96

1.4

1.3

29.91

24.52

0.41

107

(3001893) Eosinophils/100 leukocytes in Pleural fluid

186

2.16

4.96

1.3

1.5

3.52

2.45

0.29

156

(3037756) Immunofixation for Serum or Plasma

152

1041

1.47

4.93

1.3

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1192

0.58

4.93

1.3

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1635

14870

1.15

4.89

2.5

2.2

74.57

77.05

nmol/l

2.77

1468

13165

(3019832) Treponema pallidum Ab [Presence] in Serum

221

1625

1.38

4.85

1.3

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.07

4.78

3.3

5.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.17

4.75

1.0

1.3

14.34

19.59

u/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

1.85

4.70

1.3

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.59

4.63

1.6

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

268

1.91

4.57

1.3

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

268

1.91

4.57

1.3

1.6

—

(3003181) Sodium [Moles/volume] in Urine

113

740

1.54

4.57

1.6

1.3

58.83

63.07

mmol/l

0.56

589

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

407

1.73

4.54

1.1

1.2

97.08

65.73

u/l

0.36

365

(3007164) IgA [Mass/volume] in Serum or Plasma

756

6507

1.19

4.54

1.5

2.75

2.69

g/l

0.35

500

3964

(3023103) Potassium [Moles/volume] in Serum or Plasma

4205

40933

1.20

4.52

40.8

19.3

4.09

4.01

mmol/l

88.82

4143

39903

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

371

1.76

4.50

1.5

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.16

4.48

1.0

1.1

14.01

17.35

g/l

1.17

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

478

1.66

4.44

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2858

27093

1.13

4.34

4.7

4.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

600

1.58

4.27

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

165

2.13

4.24

3.3

2.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

159

2.15

4.20

1.3

1.9

86.33

100.88

umol/l

0.29

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

121

2.32

4.17

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

411

1.69

4.14

1.2

1.5

23.07

25.61

0.29

257

(3011397) Hemoglobin [Presence] in Urine by Test strip

1017

9035

1.16

4.11

3.8

3.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

458

1.65

4.10

3.1

3.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.71

4.08

1.8

1.5

149.40

122.35

ug/l

0.37

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.46

4.04

1.3

1.5

13.63

6.82

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.34

4.04

2.9

1.8

69.00

60.03

—

(3028433) Virus identified in Specimen by Culture

149

2.16

4.01

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

281

1.82

4.00

2.0

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

839

1.47

3.95

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

254

1.86

3.92

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

120

826

1.46

3.88

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.57

3.88

1.3

1.2

0.88

1.51

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

169

2274

0.73

3.82

1.3

—

(3014891) Appearance of Pleural fluid

2.68

3.82

1.5

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

302

1.76

3.75

1.0

300.81

281.31

mg/l

0.94

271

(3039000) Anion gap in Blood

149

1077

1.40

3.71

11.6

7.2

12.16

11.36

mmol/l

1.81

135

963

(3018572) Chloride [Moles/volume] in Blood

149

1077

1.40

3.71

11.6

7.2

104.52

105.19

mmol/l

0.72

135

963

(3030905) Polymorphonuclear cells [#/volume] in Blood

116

802

1.46

3.69

2.7

3.5

4.68

4.34

e9/l

0.67

116

802

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

425

1.63

3.68

1.2

1.3

1.83

1.46

nmol/l

1.58

373

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

175

2.01

3.68

1.0

1.2

1.11

1.07

ratio

—

(3002619) Bacteria identified in Specimen by Culture

2.69

3.65

1.5

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

119

830

1.44

3.62

3.2

3.8

61.87

58.29

2.33

119

830

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

659

1.50

3.58

1.2

158.81

200.57

miu/ml

0.57

236

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.35

3.57

8.2

7.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

564

1.53

3.54

2.0

2.5

1.62

1.46

g/24h

0.14

292

(3023419) Bacteria identified in Sputum by Culture

104

711

1.47

3.52

1.8

2.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

243

1.82

3.47

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

243

1.82

3.47

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

609

1.50

3.42

2.1

1.9

4.49

4.83

mmol/24h

0.44

525

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.76

3.41

1.3

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.76

3.41

1.4

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

426

3577

1.21

3.37

4.2

0.76

0.98

1.78

189

1359

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

613

1.49

3.33

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

396

3311

1.21

3.27

4.0

—

(3037121) Protein [Mass/volume] in Urine

194

1496

1.31

3.22

2.8

3.4

0.32

0.35

g/l

0.20

100

702

(3029075) Extractable nuclear Ab panel - Serum

103

2.24

3.21

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

418

1.59

3.20

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

418

1.59

3.20

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

418

1.59

3.20

1.6

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

250

1.77

3.19

2.9

3.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

419

0.45

3.16

1.2

1.4

156.78

189.36

pmol/l

0.44

419

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.26

3.13

1.2

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

390

1.60

3.10

1.4

1.3

7.30

6.89

g/l

0.37

270

(3047007) Chlamydophila sp Ab [Presence] in Serum

424

1.56

3.03

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.8

2.1

—

(4062490) Immunoglobulin typing, IgG

393

1.59

3.01

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

644

1.45

3.00

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

175

1.89

2.99

1.3

2.69

3.41

mmol/l

1.00

158

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.29

2.99

2.7

2.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

169

1.90

2.94

1.1

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

135

2.01

2.90

1.4

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.22

2.89

2.4

2.2

108.00

467.80

e6/l

0.73

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

641

1.44

2.89

1.0

1.1

—

(40761535) Cells panel - Urine sediment

416

3539

1.19

2.89

4.1

3.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

390

1.57

2.87

1.4

1.3

0.51

0.41

g/l

1.05

269

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

838

7524

1.14

2.86

2.8

3.3

2.46

2.45

mmol/l

1.34

723

6591

(3041918) Cholesterol [Moles/volume] in Pleural fluid

102

2.16

2.86

1.3

1.1

1.64

1.61

mmol/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

391

1.57

2.85

1.4

1.3

3.06

2.99

g/l

0.15

270

(3021440) Promyelocytes/100 leukocytes in Blood

398

3378

1.19

2.84

4.3

4.2

0.07

0.12

0.98

161

1167

(3011412) CD3 cells [#/volume] in Blood

392

1.56

2.82

2.6

2.5

0.91

1.11

e9/l

1.46

351

(44786800) Granulocytes/100 leukocytes in Body fluid

2.34

2.81

1.1

1.4

14.45

26.36

0.69

(3010813) Leukocytes [#/volume] in Blood

4217

42924

0.87

2.79

42.2

23.7

7.25

6.85

e9/l

11.80

4121

41613

(3000963) Hemoglobin [Mass/volume] in Blood

4218

42931

0.87

2.77

42.5

23.8

134.16

136.86

g/l

20.95

4162

42256

(21494890) Protein electrophoresis panel - 24 hour Urine

515

1.48

2.76

1.4

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

631

1.43

2.75

1.7

1.6

0.88

0.93

g/l

0.15

480

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.31

2.74

1.8

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

4218

42923

0.87

2.72

42.1

23.7

4.43

4.51

e12/l

17.19

4125

41624

(3024263) Appearance of Synovial fluid

248

1.70

2.71

1.2

1.3

—

(3024731) MCV [Entitic volume]

4218

42921

0.87

2.70

42.0

23.6

92.47

91.45

34.85

4160

42248

(3035941) MCH [Entitic mass]

4218

42918

0.87

2.69

41.9

23.5

30.54

30.52

0.20

4159

42245

(1617658) Protocol used for examination of sentinel lymph nodes

171

0.29

2.66

1.0

—

(3007461) Platelets [#/volume] in Blood

4217

42900

0.87

2.63

42.2

23.7

224.58

238.56

e9/l

36.22

4133

41749

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.67

2.59

1.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

100

2.10

2.58

1.0

1.1

—

(3049233) Organic acids panel - Urine

7.15

2.55

1.2

1.0

—

(1002224) Polysomnography panel

111

1487

0.74

2.55

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

164

1.83

2.52

1.5

1.4

32.49

21.47

0.87

149

(3009542) Hematocrit [Volume Fraction] of Blood

4217

42881

0.88

2.51

44.0

23.8

40.35

40.66

0.94

3955

39859

(3029937) Albumin [Presence] in Urine by Test strip

1137

10472

1.11

2.51

4.3

4.0

0.01

0.00

estimate

0.14

386

3382

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.38

2.47

1.0

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

379

3246

1.18

2.47

4.3

4.0

0.61

0.71

0.27

162

1176

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

302

1.60

2.46

2.6

2.5

576.88

596.06

e6/l

0.10

290

(3020191) Ethanol [Moles/volume] in Serum or Plasma

342

1.56

2.45

1.4

1.3

1.07

1.32

promille

0.66

266

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

130

1.93

2.45

1.9

2.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3791

36998

1.11

2.44

29.2

15.3

70.35

77.67

ml/min/173m2

62.87

3429

30852

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.13

2.43

1.4

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2630

25235

1.09

2.43

3.7

3.2

76.54

56.66

u/l

12.35

2456

23311

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

159

1250

1.28

2.37

2.2

137.54

119.53

ug/min

0.23

760

(3036525) Urea [Moles/time] in 24 hour Urine

3.03

2.35

2.7

3.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

328

3835

0.84

2.30

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

503

1.44

2.30

3.8

4.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

450

5129

0.86

2.28

5.0

4.7

31.65

31.99

0.28

360

3498

(3010144) Erythrocytes [#/volume] in Synovial fluid

422

1.48

2.26

1.5

1.3

116912.79

120280.02

e6/l

0.02

294

(3025159) Blasts/100 leukocytes in Blood

370

3188

1.17

2.26

4.4

4.2

0.08

0.23

0.87

133

982

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

263

1.60

2.23

2.0

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

197

2400

0.81

2.16

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.17

2.14

1.4

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

1.77

2.13

1.5

1.7

4.06

7.67

nmol/l

0.58

137

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

0.33

2.13

1.0

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.37

2.12

1.7

2.0

1.24

1.00

mmol/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.80

2.10

3.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.80

2.10

3.0

2.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.11

2.02

2.6

2.4

1.16

1.19

mmol/l

1.23

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.11

2.02

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.82

2.00

1.2

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.82

2.00

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

117

907

1.30

1.99

1.7

1.6

1.26

0.85

nmol/l

3.08

103

748

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

143

1138

1.26

1.98

1.4

1.6

2.55

13.15

iu/ml

0.84

251

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

329

1.49

1.95

1.2

1.6

21.40

26.37

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

633

5725

1.12

1.95

1.2

1.3

51.50

36.87

iu/ml

0.85

175

1782

(3000012) Reticulocyte production index

736

1.32

1.93

1.9

2.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

211

1.62

1.91

1.1

1.5

3.55

4.15

0.11

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

219

1.60

1.90

1.4

1.6

1.83

3.17

u/field

0.68

160

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

325

1.48

1.85

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

1.90

1.85

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

241

2049

1.19

1.79

1.3

191.11

270.49

u/ml

1.61

230

1875

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

981

10534

0.91

1.77

1.5

1.7

1.57

1.38

mmol/l

4.45

830

8760

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.74

2.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

201

1.60

1.73

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

129

1034

1.25

1.72

1.4

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

155

1.68

1.72

1.6

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

282

1.49

1.71

2.7

2.5

330.50

524.49

e6/l

2.55

239

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.91

1.69

1.2

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3761

36878

1.09

1.69

7.2

6.3

42.89

40.66

mmol/mol

24.23

3553

33908

(40768797) Stomach Pathology biopsy report

604

5499

1.11

1.67

1.2

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

104

1.83

1.67

2.1

2.3

7.73

7.85

mmol/l

0.05

(40759836) Histone Ab [Presence] in Serum by Immunoblot

245

1.51

1.62

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1.51

1.62

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1.51

1.62

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.57

1.61

1.0

1.1

—

(3008898) HLA-B27 [Presence]

962

0.76

1.61

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.69

1.58

2.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

578

5270

1.11

1.57

16.0

7.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

448

1.37

1.56

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1.50

1.54

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1.50

1.54

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1.50

1.54

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

290

1.45

1.52

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

178

1.58

1.48

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

267

1.46

1.48

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

359

1.40

1.48

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.22

1.46

1.0

1.3

—

mmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

330

0.60

1.46

1.0

260.73

311.27

ng/l

0.40

226

(40768446) Kidney Pathology biopsy report

171

1.58

1.45

1.8

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1158

0.79

1.45

1.6

1.9

202.55

207.33

pmol/l

0.23

1086

(3005011) Chlamydia sp Ab [Titer] in Serum

2.37

1.45

1.4

1.7

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.13

1.44

6.0

2.9

4.28

4.59

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

0.46

1.43

1.0

—

(3016228) CD19 cells/100 cells in Blood

164

1.59

1.43

1.8

2.1

11.42

8.25

0.33

155

(3015171) Extractable nuclear Ab [Units/volume] in Serum

150

1253

1.20

1.41

1.2

0.13

0.72

u/ml

—

109

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

130

1071

1.22

1.41

1.3

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

2304

0.85

1.41

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

262

1.45

1.40

2.2

2.1

87.45

205.51

ug/min

0.65

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

287

1.43

1.40

1.2

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.80

1.37

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

1471

15391

0.94

1.33

2.1

2.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

0.47

1.31

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

0.47

1.31

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

0.47

1.31

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

0.47

1.31

1.3

1.4

—

(3019225) pH of Specimen

460

4190

1.11

1.30

6.1

4.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.50

1.30

15.2

9.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

331

0.63

1.29

1.0

35.47

43.92

ng/l

0.47

222

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

331

0.63

1.29

1.0

747.33

707.60

ng/l

0.16

221

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.78

1.28

1.4

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

330

0.63

1.28

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.00

1.27

1.5

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.29

1.26

1.9

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

840

1.23

1.26

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

158

0.51

1.24

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

503

1.30

1.23

1.4

1.3

0.20

0.27

nmol/l

0.38

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

237

1.44

1.22

1.6

1.4

11.78

7.19

u/l

0.33

201

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.16

1.21

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

142

1202

1.19

1.20

1.5

256.82

263.71

ug/g

0.16

731

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

272

1.40

1.19

2.8

2.6

0.25

0.24

e9/l

0.09

239

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.75

1.18

1.7

3.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.16

1.6

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.16

1.6

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.16

1.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

190

1.48

1.16

1.9

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

190

1.48

1.16

1.9

2.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

741

1.23

1.15

1.1

1.2

—

22.09

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

417

4559

0.91

1.15

1.4

—

(3025130) Human papilloma virus identified in Specimen

150

1.54

1.14

1.7

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

361

1.33

1.13

1.7

2.2

1141.16

3225.30

u/l

0.75

128

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.34

1.12

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.34

1.12

1.1

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

1961

18973

1.06

1.11

5.0

4.8

0.00

estimate

0.50

429

3622

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

242

1.41

1.11

1.7

1.6

5.82

8.11

u/l

0.34

196

(3045142) Bone marrow Pathology biopsy report

529

1.27

1.11

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1106

0.82

1.11

2.0

1.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.26

1.10

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

1.45

1.09

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

352

0.68

1.09

4.7

3.6

27.17

37.11

u/ml

0.50

343

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.38

1.09

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.82

1.08

2.6

1.7

218.42

185.82

ng/l

0.15

(3008037) Lactate [Moles/volume] in Venous blood

122

1030

1.19

1.08

4.3

3.4

1.61

1.66

mmol/l

0.37

117

1001

(3035350) Ketones [Presence] in Urine by Test strip

1966

19035

1.06

1.08

3.9

3.6

0.00

estimate

1.98

443

3845

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

286

1.37

1.08

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

1.56

1.08

1.0

1.1

1636.15

1583.91

miu/ml

0.07

128

(3032773) Endomysium IgG Ab [Titer] in Serum

267

0.64

1.07

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

1.65

1.06

1.1

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

217

2447

0.88

1.06

2.2

2.4

8.90

21.38

au/ml

—

152

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

105

1.62

1.05

1.9

1.5

10.13

9.25

ug/l

0.25

105

(3041096) Erythrocytes [Presence] in Urine by Automated

961

10119

0.94

1.05

3.6

3.4

—

(3005033) Fetal Nuchal fold Thickness US

121

0.50

1.05

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

121

0.50

1.05

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

123

0.49

1.05

1.2

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

170

1.47

1.04

1.5

2.2

5.15

11.37

umol/l

0.97

108

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

845

0.80

1.04

1.2

1.1

12.41

7.49

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

2.27

1.03

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

495

0.75

1.00

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

274

1.35

0.98

2.8

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

1166

0.84

0.98

4.7

4.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

827

0.81

0.97

1.4

103.75

21.09

e6/l

0.45

645

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

826

0.81

0.97

1.4

1.5

320.92

904.21

e6/l

1.05

679

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.95

0.0

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.69

0.95

1.5

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

515

1.25

0.94

1.7

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1978

19210

1.05

0.94

3.9

3.6

0.01

0.00

estimate

0.21

391

3433

(3045414) Leukocytes [Presence] in Urine

198

1759

1.13

0.93

2.0

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

117

1.54

0.93

1.0

1.2

—

(40761511) CBC panel - Blood by Automated count

4055

40109

1.07

0.93

26.5

15.4

—

(21494434) Karyotype in Bone marrow

438

1.26

0.89

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

236

1.36

0.89

2.2

3.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

211

1.38

0.88

2.0

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

744

7048

1.07

0.87

1.2

2.18

2.08

u/ml

0.04

188

1824

(3019174) dRVVT (LA screen)

2.00

0.87

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

370

1.27

0.85

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1419

14686

0.95

0.84

4.2

3.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.59

0.84

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

137

1.46

0.84

1.4

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

470

1.24

0.83

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

443

1.24

0.83

1.4

1.3

—

nmol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

112

0.54

0.83

2.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

139

1219

1.14

0.82

1.7

1.6

—

(3020491) Glucose [Moles/volume] in Blood

301

1.30

0.82

2.1

2.0

8.70

6.96

mmol/l

1.19

208

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

113

1.51

0.82

1.2

36.82

29.28

0.28

(40768793) Breast Pathology biopsy report

464

0.77

0.79

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

195

1753

1.12

0.79

1.2

109.34

121.62

iu/ml

0.16

600

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

114

1.49

0.79

1.1

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

9.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

222

0.67

0.77

9.7

6.0

51.00

681.92

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

807

8448

0.95

0.75

4.7

4.0

1.02

kg/l

1.14

116

1277

(3014271) Vancomycin [Susceptibility]

244

1.31

0.75

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

192

1.36

0.75

1.9

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

218

1.33

0.75

1.3

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

218

1.33

0.75

1.3

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

470

0.79

0.74

1.3

1.1

0.69

2.19

u/ml

2.49

247

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1.34

0.73

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

402

0.77

0.73

1.1

1.22

1.42

u/ml

0.07

174

(3010726) Horse dander IgE Ab [Units/volume] in Serum

368

0.76

0.73

1.2

1.1

1.76

1.55

u/ml

0.08

190

(3028707) Methadone [Presence] in Urine by Screen method

361

1.25

0.73

3.4

2.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

311

0.74

0.72

1.2

1.0

4.70

2.76

u/ml

0.24

149

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.80

0.72

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

0.56

0.72

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3779

38189

0.95

0.72

5.4

4.9

6.44

6.10

mmol/l

32.13

3481

34506

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3911

39484

0.95

0.70

5.8

5.2

2.41

2.63

mmol/l

46.02

3691

36120

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

275

0.73

0.70

4.1

5.2

32.42

47.66

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

252

0.71

0.70

1.1

1.0

1.08

0.49

u/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

761

0.84

0.70

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.71

0.70

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

583

1.19

0.69

3.5

2.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

104

909

1.15

0.68

1.1

1.2

—

37.08

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.64

0.68

1.0

1.6

2.58

1.61

ug/l

—

(40768441) Liver Pathology biopsy report

284

1.27

0.68

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

0.59

0.67

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

168

0.65

0.67

1.1

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.79

0.66

1.2

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.79

0.66

1.8

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

128

1.41

0.65

1.0

1.1

7.46

4.19

u/ml

—

(3017704) Immunofixation for Urine

277

1.27

0.65

1.4

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4124

41559

0.95

0.65

16.3

11.0

29.50

27.78

u/l

2.29

4011

39977

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

1.46

0.64

1.8

1.5

61.60

320.25

nmol/24h

1.33

103

(3022621) pH of Urine by Test strip

280

2596

1.08

0.64

2.9

3.0

—

(3041354) Potassium [Moles/volume] in Venous blood

597

1.18

0.64

3.5

2.5

4.20

4.11

mmol/l

0.86

587

(3035285) Chloride [Moles/volume] in Venous blood

597

1.18

0.64

3.5

2.5

105.57

105.73

mmol/l

0.08

587

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

0.58

0.62

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.59

0.61

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.67

0.61

4.0

3.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.67

0.61

1.4

2.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.60

0.0

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

203

2209

0.92

0.60

1.2

1.3

48.38

60.52

au/ml

—

127

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3753

37170

1.04

0.60

4.9

4.2

1.47

1.33

mmol/l

19.96

3528

33694

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

853

0.87

0.58

1.3

3.85

3.88

mmol/l

0.08

798

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

112

0.62

0.58

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

0.61

0.58

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

106

1.42

0.57

1.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.48

0.57

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

633

1.16

0.56

1.1

187.56

289.98

iu/ml

—

142

(3023430) Cat dander IgE Ab [Units/volume] in Serum

286

0.77

0.56

1.1

1.0

11.05

3.71

u/ml

—

116

(3036180) Methadone [Presence] in Urine

124

1.37

0.55

1.8

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

497

1.17

0.53

3.1

3.8

63.46

56.74

1.57

415

(3050129) First trimester maternal screen panel - Serum or Plasma

170

0.71

0.53

1.6

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

359

1.20

0.52

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

0.62

0.52

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

146

0.68

0.52

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.61

0.52

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

237

0.76

0.51

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

179

1.29

0.51

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

413

0.82

0.51

1.1

8.66

4.51

u/ml

0.53

201

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

436

4581

0.95

0.51

3.2

4.3

9.11

24.41

ug/l

3.00

354

3850

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

261

1.23

0.49

2.3

2.9

43.13

36.92

1.11

156

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1.24

0.49

1.4

1.3

1.73

1.15

nmol/l

1.07

172

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.56

0.49

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

0.49

1.4

1.9

—

(3044927) Protein electrophoresis panel - Urine

483

1.16

0.48

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2132

20961

1.03

0.48

2.5

—

(3000330) Specific gravity of Urine by Test strip

201

2161

0.93

0.48

3.8

3.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.49

0.47

1.6

2.4

0.14

0.36

u/field

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

0.76

0.47

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.46

0.46

1.1

1.5

50.29

44.90

umol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

191

1.26

0.46

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

153

0.72

0.45

1.9

1.6

24.36

27.79

umol/l

1.28

147

(3047189) Immunofixation for 24 hour Urine

246

1.22

0.45

1.4

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.40

0.45

1.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

799

1.12

0.44

3.4

3.7

1.71

1.62

0.08

701

(3011897) Casein IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.3

0.05

1.23

u/ml

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

560

5391

1.04

0.42

1.2

11.80

12.96

u/ml

0.15

212

1990

(3036048) Francisella tularensis Ab [Titer] in Serum

0.65

0.42

1.3

1.2

—

624.00

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.64

0.42

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

360

0.83

0.42

1.2

355.84

342.57

nmol/l

0.11

289

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.38

0.42

1.2

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.41

1.0

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.3

—

27.31

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

138

0.72

0.40

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.47

0.40

1.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.33

0.40

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.40

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

149

0.74

0.40

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

603

0.88

0.40

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

864

1.10

0.39

1.1

1.2

2.96

7.29

u/ml

1.42

128

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.39

3.8

2.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

169

1.24

0.38

1.1

1.3

172.62

182.74

mmol/24h

0.22

169

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.38

0.38

1.3

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

515

1.13

0.37

1.2

1.3

—

(3022689) Creatine [Moles/volume] in Urine

125

1.28

0.37

1.5

—

(3048879) Bone marrow aspiration report

143

1.26

0.36

2.0

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

180

0.78

0.36

1.1

0.97

1.17

u/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

213

0.80

0.36

1.0

1.4

1.45

1.50

g/l

0.34

213

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

126

1.27

0.35

2.8

2.0

85.36

58.48

ug/l

0.49

121

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

992

0.92

0.34

2.2

3.6

1049.20

741.88

u/ml

0.19

924

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

172

1.22

0.34

1.1

1.3

1.44

296.51

ug/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

457

0.87

0.33

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

293

1.16

0.33

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

199

0.80

0.33

5.2

6.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.70

0.33

1.5

1.1

14.40

16.18

umol/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

456

0.88

0.33

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

173

1.21

0.32

1.4

1.6

9.56

9.88

ug/l

0.03

152

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

100

923

1.09

0.32

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.28

0.32

1.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

101

1.29

0.31

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

295

1.15

0.31

1.8

1.6

98.06

91.65

umol/l

0.49

295

(3011985) Renin [Units/volume] in Plasma

532

1.11

0.31

1.4

65.05

65.03

mu/l

0.00

474

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.31

0.30

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

851

1.08

0.29

1.2

3.22

3.69

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

188

1784

1.06

0.29

1.6

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.28

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

248

0.85

0.28

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

161

0.81

0.27

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

1.20

0.26

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

159

1.20

0.26

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

159

1.20

0.26

2.8

3.8

59.08

55.41

0.33

154

(3009466) Valproate [Moles/volume] in Serum or Plasma

604

0.91

0.26

4.3

4.9

324.43

352.92

umol/l

0.83

513

(3032057) Clostridioides difficile [Presence] in Stool

104

1.25

0.26

1.7

2.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

234

1.15

0.26

1.4

0.63

1.82

u/ml

1.05

137

(3036670) Protein [Mass/volume] in Synovial fluid

141

1.21

0.26

1.0

1.2

37.84

39.63

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

141

1488

0.95

0.25

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

151

1.19

0.25

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3814

38315

0.98

0.24

5.2

4.6

1.24

1.37

mmol/l

85.73

3597

35011

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

191

0.84

0.24

1.8

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

111

1045

1.06

0.24

2.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.32

0.23

1.0

1.2

4.20

12.13

u/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.32

0.23

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.28

0.23

1.8

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3845

38611

0.98

0.22

5.3

4.7

4.13

4.46

mmol/l

72.91

3646

35535

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

452

0.91

0.22

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

613

1.08

0.21

2.7

2.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

273

0.88

0.21

1.2

1.6

0.90

0.95

g/l

0.68

273

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.19

0.21

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.01

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.21

0.0

1.0

—

1216.00

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

102

0.78

0.21

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

0.78

0.21

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

935

1.06

0.21

1.5

1.4

10.05

7.65

u/l

0.93

752

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3049717) Cytology report of Urine Cyto stain

221

2132

1.04

0.20

2.9

2.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(3015736) pH of Urine

1541

15242

1.02

0.20

3.7

3.3

5.68

5.76

0.34

929

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.21

0.19

1.1

1.3

—

(3022145) Colonoscopy Study observation

459

4489

1.02

0.19

1.3

1.4

—

(40768443) Skin Pathology biopsy report

185

1783

1.04

0.18

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

109

1.19

0.18

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

435

1.08

0.17

1.6

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.21

0.17

1.1

1.3

—

(3000285) Sodium [Moles/volume] in Blood

0.76

0.17

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

875

1.05

0.16

1.3

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

495

1.07

0.16

1.2

1.4

318.21

294.29

pmol/l

0.17

420

(3051387) C reactive protein [Mass/volume] in Capillary blood

915

0.95

0.16

5.4

3.5

26.71

29.15

mg/l

0.30

579

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

298

0.91

0.16

1.0

1.1

—

83.92

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

515

1.07

0.16

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

515

1.07

0.16

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

360

0.92

0.16

1.6

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

206

1.12

0.16

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.13

0.15

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

517

1.06

0.15

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

778

0.95

0.14

2.8

2.1

—

(3003129) Base excess in Capillary blood by calculation

131

1.15

0.14

2.9

1.7

0.49

0.63

mmol/l

0.03

125

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

118

0.85

0.14

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

904

8936

1.01

0.14

1.7

24803587.33

33094331.36

pmol/l

0.18

762

7379

(3024522) Salmonella sp identified in Specimen by Organism specific culture

519

1.06

0.13

1.3

1.5

—

(3006462) Nitrate [Presence] in Urine

180

0.89

0.13

2.6

3.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

106

0.85

0.13

1.3

1.2

120.67

109.57

—

(3000764) Benzodiazepines [Presence] in Urine

785

0.95

0.13

2.8

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

433

1.06

0.12

3.5

3.2

12.38

63.54

mg/l

2.16

338

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

123

1.14

0.12

2.2

2.4

149.57

137.65

nmol/l

0.18

107

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

137

0.88

0.12

1.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

793

0.96

0.12

2.8

2.1

—

(3002256) Pathology report gross observation

520

5271

0.98

0.11

1.3

—

(3027008) Opiates [Presence] in Urine

791

0.96

0.11

2.8

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

524

1.05

0.10

1.3

1.5

—

(3003338) MCHC [Mass/volume]

3208

32179

0.99

0.10

40.0

20.8

329.86

333.22

g/l

73.83

3169

31915

(3003694) ABO and Rh group [Type] in Blood

1038

10463

0.99

0.10

1.4

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.09

0.09

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.06

0.09

1.0

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

383

3883

0.99

0.09

2.0

2.4

147.19

163.80

ug/g

0.38

302

3112

(3045424) Erythrocytes [Presence] in Urine

665

1.04

0.09

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

400

0.95

0.08

1.1

2.44

2.56

u/ml

—

165

(3025577) Chromium [Mass/volume] in Blood

318

0.94

0.08

2.0

2.1

1.76

2.13

ug/l

0.38

267

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.80

0.07

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.04

0.07

8.5

6.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

217

2203

0.98

0.07

2.6

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

204

0.93

0.07

1.3

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

162

1649

0.98

0.07

2.5

3.6

408.98

3368.00

u/ml

1.05

132

1431

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.02

0.07

1.3

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

446

0.96

0.06

1.1

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

129

1.09

0.05

1.1

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

198

1.06

0.05

9.3

14.6

1038.24

781.58

nmol/l

1.42

184

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

515

1.03

0.05

1.4

1.5

—

(4034850) Laboratory test

130

1280

1.02

0.05

24.4

10.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

694

1.02

0.04

1.7

2.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4158

41615

0.99

0.04

37.7

19.1

99.94

84.78

umol/l

64.41

4153

41600

(4146454) Self-monitoring of blood glucose

513

0.97

0.04

2.7

2.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

371

0.97

0.03

1.3

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

548

1.02

0.03

1.6

2.2

18.58

22.79

mg/l

0.28

131

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.09

0.03

1.1

—

(3008295) Osmolality of Serum or Plasma

430

1.02

0.02

1.4

1.3

278.79

280.37

mosm/kgh2o

0.12

328

(3015183) Erythrocyte sedimentation rate

138

0.94

0.02

1.5

1.2

—

(3017732) Neutrophils [#/volume] in Blood

269

2674

1.01

0.02

2.8

3.3

6.15

5.41

e9/l

0.22

207

2099

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

342

1.02

0.01

1.6

2.0

1.53

1.83

u/field

0.12

130

(3004775) Volume in Urine collected for unspecified duration

422

1.02

0.01

2.3

2.2

717.93

635.00

0.52

270

(3016879) Cocaine [Presence] in Urine

738

0.99

0.01

2.8

2.2

—

(36660697) Celiac disease serology panel - Serum

253

2540

1.00

0.01

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

377

0.98

0.01

1.4

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

503

1.01

0.01

3.5

3.4

12.96

17.36

nmol/l

0.15

496

(3020961) Endomysium IgA Ab [Titer] in Serum

146

1452

1.01

0.01

1.1

28.33

189.27

titre

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

697

0.99

0.01

1.5

1.4

30.09

26.97

iu/l

0.27

579

(3024869) Neuronal Ab [Presence] in Serum

1.06

0.01

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

126

0.95

0.00

1.9

—

(44813793) Dust mix specific IgE antibody measurement

196

0.97

0.00

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

254

1.02

0.00

1.5

1.3

19.39

23.52

u/l

0.35

207

(3016018) Differential panel - Cerebral spinal fluid

396

0.98

0.00

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

514

1.01

0.00

9.3

2.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

215

1.02

0.00

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

558

1.00

0.00

1.6

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

104

0.96

0.00

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

204

0.98

0.00

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

216

1.02

0.00

1.0

1.3

—

(3016750) Collection duration of Urine

297

1.01

0.00

2.2

2.1

504.45

489.15

min

0.37

213

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

109

1.01

0.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

109

1.01

0.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

109

1.01

0.00

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

109

1.01

0.00

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

131

0.99

0.00

4.2

2.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

196

1963

1.00

0.00

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.25

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.3

—

(3039528) Macrophages/100 leukocytes in Pleural fluid by Manual count

0.00

0.0

3.8

—

32.50

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1868.33

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

2.50

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.98

0.00

4.0

4.9

52.33

48.52

ug/min

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.02

-0.00

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.02

-0.00

2.7

1.6

46.02

41.14

pmol/l

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.26

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.93

-0.00

1.4

2.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.02

-0.00

1.0

2.2

15.52

17.09

umol/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

4.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.92

-0.00

1.1

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.28

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.92

-0.00

1.3

3.12

3.34

umol/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

1.00

-0.00

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.00

-0.00

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: I9_DILATED_CARDIOMYOPATHY – Dilated cardiomyopathy

GWS hits: 23

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dilated cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dilated cardiomyopathy (I9_DILATED_CARDIOMYOPATHY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints